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INTRODUCTION 
Evidence indicates activated proto-oncogenes (oncogenes) 
play a causal role in the induction of human cancer. Thus, 
it follows that delineating the effects of anti-tumor agents 
on oncogene structure and function ultimately may be of 
chemotherapeutic significance. Al though the mechanisms by 
which oncogenes induce malignant growth continue to be 
defined, the effects of DNA-damaging anti-tumor agents on 
oncogene structure and function are not understood. The goal 
of this dissertation project was to characterize the effects 
of clinically-used bifunctional alkylating agents on oncogene 
structure and function, and was predicated on the hypothesis 
that these compounds may affect differentially the function 
of these genes. 
The anti-tumor agents examined in this study were the 
bifunctional alkylating agents mechlorethamine (HN2, nitrogen 
mustard), L-phenylalanine mustard (L-PAM), and forms of 
cyclophosphamide which are active in vitro - 4-S-(propionic 
acid)-sulfidocyclophosphamide (C2) and 4-hydroperoxy-
cyclophosphamide ( 4-HC). These agents are cytotoxic, and 
experimental evidence suggests that the DNA interstrand 
cross link is a critical cytotoxic cellular lesion. This 
lesion is formed by the covalent binding of the bis-
chloroethyl group of the alkylating agent to the N7 position 
1 
2 
of guanines on opposite strands of the DNA, and may alter the 
transcription, and ultimately the replication, of oncogenes. 
To help characterize the actions of DNA-damaging anti-tumor 
agents on oncogenes, the effects of the aforementioned 
bifunctional alkylating agents on a number of parameters 
regarding gene structure and function were explored. 
Specifically, studies presented in this dissertation attempted 
to address the following questions: 
1) Do differences exist between the bifunctional 
alkylating agents, HN2, L-PAM, and C-2, in their ability to 
react with the N7 position of guanine in the primary sequence 
of the c-myc oncogene in vitro? 
2) Do HN2, L-PAM, and 4-HC differentially affect the 
steady state expression of specific oncogenes within a given 
human tumor cell line? 
3) Are gene-specific DNA interstrand cross links 
responsible for any changes seen in the steady state 
expression of these genes? 
To perform these studies a human tumor cell line, Colo320 
HSR, was used as a model system. This cell line was chosen 
because it was of human origin, it was obtained from the 
patient prior to the onset of chemotherapy, and it expressed 
an activated oncogene (c-myc). Exposures of HN2, L-PAM, or 
4-HC used for these studies were chosen for their ability to 
produce one or three logs of cell kill in Colo320 HSR cells, 
as determined by soft agar colony formation assays. Using a 
3 
modification of the Maxam and Gilbert DNA sequencing 
technique, it was possible to determine the extent of N7 
guanine modification produced by these anti-tumor agents in 
vitro, using an exon 2 fragment of the c-myc oncogene as the 
probe. The c-myc fragment used in these studies originally 
was isolated and cloned from the Colo320 HSR cell line. 
Effects of drug exposure on the steady state levels of gene 
expression in Colo320 HSR were determined by Northern blot 
analysis. Gene-specific cross links were measured by the 
combined use of DNA denaturation-renaturation gel 
electrophoresis and Southern blot analysis. 
REVIEW OF RELATED LITERATURE 
oncogenes 
The genetic basis of cancer has been a tenet of cancer 
biology for almost a century. It was not until recently 
however, that it was proven that specfic genes play a causal 
role in oncogenesis. In 1969, work by Huebner and Todaro led 
them to propose that cancer genes, or oncogenes, existed in 
the genome of RNA tumor viruses, and were transmitted from 
parent to progeny in a covert form. It was further 
hypothesized that damage to these genes would result in their 
activation (Huebner and Todaro, 1969). This suggestion proved 
to be incorrect. In 1976, experiments by Bishop and Varmus 
demonstrated unequivocally that the oncogene of the Rous 
Sarcoma virus is found in the genome of higher organisms, 
suggesting that the virus had transduced the gene from 
eukaryotic organisms (Stehlin et al., 1976). 
The cellular homologs of viral oncogenes have been termed 
proto-oncogenes (Bishop, 1983). These proto-oncogenes are not 
inherently cancerous, but instead their conservation 
throughout evolution suggests that proto-oncogenes play a 
fundamental role in normal cellular function and evolutionary 
development (Bishop, 1987). The proteins encoded by proto-
oncogenes include growth factors and their receptors, plasma 
membrane proteins involved in signal transduction, and nuclear 
4 
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proteins involved in transcriptional regulation and perhaps 
DNA replication (Chiu et al.,1988, Studzinski et al.,1986, 
Fleming et al., 1989, Bos, 1988, Coussens et al. 1986). 
The activation of a proto-oncogene to an oncogene can 
occur by a wide variety of mechanisms, but all involve the 
disruption of the integrity of the gene. For instance, a 
single point mutation in the protein coding region of the ras 
family of proto-oncogenes gives rise to a non-conservative 
amino acid substitution, and hence an altered protein with 
oncogenic potential (Capon et al., 1983). Another mechanism 
is chromosomal translocation involving proto-oncogenes, which 
may lead to the disruption of normal gene regulation (e.g. c-
myc) or the production of a modified protein (e.g. c-abl); 
either event is capable of oncogenic transformation (Battey 
et al. 1983, Heisterkamp et al. 1983, Shtivelman et al. 1985). 
Finally, the amplification of proto-oncogenes, resulting in 
increased copies of the gene and increased levels of the gene 
product within the cell is also a method of inducing 
transformation (e.g. c-myc and N-myc)(Collins and Groudine, 
1982, Schwab et al. 1983). 
A number of studies have shown activated oncogenes to 
play a pivotal role in human neoplasia. Furthermore, it has 
been hypothesized that two cooperating, activated oncogenes 
are necessary to transform a normal cell to a malignant cell 
(Land et al. 1983). Although evidence supporting this 
hypothesis has been achieved in vitro, it has been difficult 
6 
to demonstrate this hypothesis in vivo. The activation of a 
single proto-oncogene in vivo however, has been readily 
demonstrated, and more importantly the activation of specific 
oncogenes have been shown to occur consistently in some tumor 
types. For example, a somatic mutation in the K-ras proto-
oncogene has been implicated in playing a role in virtually 
all tumors of the exocrine pancreas (Almoguera et al. 1988). 
The Philadelphia chromosome involves a reciprocal chromosome 
9 to chromosome 22 translocation, is indicative of a disrupted 
c-abl proto-oncogene, and is observed in 90% of patients with 
chronic myelogenous leukemia (Teich 1986). Finally, 
amplification of the N-myc proto-oncogene is frequently 
observed in neuroblastoma, and more importantly the level of 
amplification of N-myc (> 10 copies) is strongly correlated 
with a poor clinical prognosis (Schwab et al. 1984, Brodeur 
et al. 1984). 
Although much is known of the role oncogenes play in 
carcinogenesis, a paucity of data exists regarding the effects 
of DNA-damaging anti-tumor agents on oncogene structure and 
function. It is conceivable, however, that different anti-
tumor agents may inhibit selectively the expression of 
specific oncogenes. For example, a preliminary report 
indicated that exposure of the Burkitt lymphoma cell line 
Daudi to HN2 caused suppression of c-myc expression, but did 
not affect ras expression (Watt et al. 1986). Another report 
examined the effect of a variety of clinical anti-leukemic 
7 
chemotherapeutic regimens on c-myc expression in patients with 
leukemia (Venturelli et al., 1988). Although no alkylating 
agents were included in the chemotherapeutic regimens 
employed, this study demonstrated that depression of c-myc 
expression 24 hours after treatment correlated with tumor 
response in patients with acute myelogenous leukemia or acute 
lymphocytic leukemia. These data suggest that drug effects 
on oncogene expression may ultimately serve as indicators of 
prognosis in specific types of cancer. 
Colo320 HSR 
The cell line, Colo320 HSR, is a human colon carcinoma 
of neuroendocrine origin, isolated from a patient prior to the 
onset of chemotherapy (Quinn et al., 1979). Consistent with 
this cell line being derived from the neuroectoderm are the 
products it synthesizes and secretes. These include 
epinephrine, norepinephrine, serotonin, parathyroid hormone, 
and adrenocorticotrophic hormone. Furthermore, this cell line 
does not produce carcinoembryonic antigen, nor does it 
demonstrate morphologic characteristics consistent with it 
being of epithelial origin (Quinn et al. 1979). Colo320 HSR 
contains a homogeneously staining region (HSR) indicative of 
gene amplification, and in fact, contains approximately 30 to 
40 copies of the c-myc oncogene (Alitalo et al., 1983). In 
addition to the amplification and high expression of the c-
myc oncogene, we also have detected low levels of expression 
8 
of two other oncogenes; N-ras and c-fos. The salient features 
of each gene are discussed below. 
c-myc 
The c-myc gene has been intensely studied, however, the 
gene and its functional role remain enigmatic. c-myc is a 
member of an oncogenic multigene family which also includes 
the genes N-myc and L-myc (Nau et al., 1985, Kohl et al. 
1986). 
The activation of c-myc from proto-oncogene to oncogene 
is attributed to either the amplification or translocation of 
the gene, or retroviral integration near the gene locus 
(Hayward et al., 1981, Little et al. 1983, Taub et al. 1982). 
It appears that over production of a c-myc mRNA and protein 
are responsible for oncogenic activation. c-myc activation 
has been implicated in the induction of tumors of the colon, 
lung, breast, thyroid, and prostate, as well as glioblastomas 
and hematological malignancies (Trent et al. 1986, Escot et 
al. 1986, Yamashita et al. 1986, Dalla Favera et al. 1982, 
Calabretta et al. 1985, Fleming et al. 1986, Slamon et al. 
1984, Yokota et al. 1986). The widespread role that c-myc 
appears to play in human oncogenesis makes the delineation of 
c-myc responses to chemotherapeutic agents a worthwhile 
venture. 
The c-myc gene is mapped to chromosome 8q24, and is 
composed of three exons and two intrans (Taub et al. 1982). 
9 
exon 1 is an unusually long untranslated leader sequence while 
exons 2 and 3 contain the protein coding information (Kohl et 
al. 1986). 
The mature messenger RNA (mRNA) transcript coded for by 
c-myc has been reported to be 2.1-2.7 kb in both normal and 
malignant cells, and has a half life (t 1/2) of 20-30 minutes 
(Kohl et al. 1986). The gene is expressed in proliferating 
cells and can be induced in resting cells by a variety of 
stimuli including serum, platelet-derived growth factor 
(PDGF), and interleukin-1 alpha (Armelin et al. 1984, Kovacs 
and Oppenheim 1986, Cole 1986, Kelly and Siebenblast 1986). 
The predicted molecular weight for the c-myc protein 
derived from nucleic acid sequences is 49 kd, however, SDS 
polyacrylamide gel electrophoresis (PAGE) measurement yields 
two bands migrating at approximately 66 and 62 kd (Persson and 
Leder, 1984). The reason for this anomaly is not known, but 
it is not due to multiple RNA species. A recent report 
suggests that the larger form originates from a non-AUG 
initiation codon in the mRNA near the 3' end of exon 1 (Hann 
et al., 1988). The c-myc protein, a phosphoprotein localized 
in the nucleus of normal and tumor cells, is capable of 
binding single-stranded and double-stranded DNA, and has a t 
1/2 of about 30 minutes (Persson and Leder, 1984). The 
function of the c-myc protein is unknown, but may be involved 
in DNA replication or transcriptional regulation (Studzinski 
et al., 1986, Lech et al. 1988). 
10 
N,:-RaS 
Like c-myc, N-ras is a member of an oncogenic multigene 
family which includes the H-ras and K-ras genes and two 
pseudogenes. The activation of the N-ras proto-oncogene to 
its oncogenic form can occur by a single point mutation in 
codons 12, 13, or 61. These mutations lead to a single amino 
acid subs ti tu ti on in the protein, which leads to altered 
protein function. Enhanced expression of the N-ras gene also 
leads to oncogenic activation, as in the case of gene 
amplification. Thus, it appears that overproduction of a 
normal ras protein, or the normal production of a mutated 
protein are both mechanisms for oncogenic activation of ras 
genes. Activated N-ras has been implicated as a transforming 
gene in an assortment of tumors including neuroblastoma, 
mammary carcinoma, fibrosarcoma melanoma, leukemia, and 
rhabdomyosarcoma (Taparowsky et al., 1983, Shimzu et al. 1983, 
Bos, 1988). 
The N-ras gene is located on chromosome 1 and is composed 
of four exons with exon 1 being an untranslated leader 
sequence (Hall et al., 1983). The protein product is located 
on the cytoplasmic surface of the cell membrane, can bind GTP 
and GDP, and has GTPase activity. The above facts suggest 
that this protein is a G-protein involved in signal 
transduction from membrane bound receptors to adenylate 
cyclase (Bos, 1988). 
11 
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The c-fos gene has been implicated in normal cell growth, 
differentiation, and development. The gene has been mapped to 
chromosome 14q21-31, and is composed of four protein coding 
exons. It gives rise to a mature mRNA transcript of 
approximately 2.2 kb, which can be detected at high levels in 
some normal tissues, notably a wide variety of prenatal 
tissues and postnatal hemopoietic cells. It also is found at 
extremely low levels in a number of other tissues (van 
straaten et al., 1983, Verma and Graham, 1987). 
To activate the oncogenic potential of the c-fos gene two 
perturbations to the gene must occur. First, a strong 
promoter (such as a retroviral long terminal repeat) must be 
inserted near the gene's 5' end, and secondly, a 67 base pair 
stretch located in the gene's 3' non-coding region must be 
removed. The strong promoter serves to amplify normal 
transcription, and the 67 bp deletion is presumed to stabilize 
the c-fos mRNA transcript (Miller et al., 1984). From these 
observations it appears oncogenic activation of c-fos involves 
the aberrant expression of a normal protein. 
Interestingly, the c-fos gene can be induced rapidly and 
transiently following various stimuli in a number of different 
tissues and cell lines. The induction can be observed within 
a few minutes following stimulation, and can disappear within 
one hour (Greenberg and Ziff, 1986). For example, 
pheochromocytoma cell lines exhibit c-fos expression following 
12 
stimulation by cholinergic agonists (e.g. nicotine) and nerve 
growth factor. In vivo, cells of the CNS can be induced to 
express c-fos by sensory stimulation, electrically-induced 
seizures, or chemically-induced seizures (e.g. with metrazole) 
(Greenberg et al., 1986, Hunt et al., 1987, Dragunow and 
Robertson, 1987 Morgan, 1987). Non-neuronal cells also can 
be stimulated to induce c-f os expression by a wide variety of 
agents, including platelet-derived growth factor, epidermal 
growth factor, phorbol esters, and the mitogens concanavalin 
A and lipopolysaccharides (Kruiger et al., 1984, Greenberg 
and Ziff, 1984, Muller et al., 1984). 
The protein product of the c-fos gene is a nuclear 
phosphoprotein with an apparent molecular weight of 62 kd. 
This protein functions as a transcriptional regulator, is 
associated with other transcriptional proteins, and the 
protein appears to regulate its own expression (Rauscher et 
al., 1988, Sassone-Corsi et al., 1988, Lech et al., 1988). 
From these observations it has been speculated that c-fos acts 
as a third messenger - coupling short term stimuli to long 
term responses through the alteration of gene expression 
(Sagar et al., 1988). 
a-Satellite DNA 
a-satellite DNA is composed of a family of DNA sequences 
found in the genome of many vertebrates. The majority of a-
satellite DNA exists as a series of tandemly repeated 
monomers. 
13 
In the human genome the monomer is approximately 
l71 bp in length. In turn, the tandemly repeated monomer is 
part of a higher order array. The higher order array can 
continue, uninterrupted by non-alpha sequences, for as much 
as several million base pairs, and can account for several 
percent of the entire human genome. These sequences are 
localized to the heterochromatic centromeric regions of the 
chromosome. The a-satellite DNA is not a gene and produces 
no protein product. a-satellite sequences are not transcribed 
into RNA; thus the function of a-satellite DNA is not well 
understood (Willard, 1987). 
Although unclear funtionally, a-satellite DNA 
organization is becoming clearly defined. Studies indicate 
that these a-sequences are organized in a highly chromosome-
specif ic fashion in the human genome. These chromosomal 
subsets display different higher-order organization based on 
different multimers of the approximately 171 bp monomer. It 
is this organization which is chromosome-specific. 
chromosome-specific, higher-order repeats can 
The unique 
often be 
revealed by restriction enzyme digestion and Southern blot 
analysis (Willard, 1985, Waye et al., 1988). 
The chromosomal a-satellite DNA examined in this project 
is specific for human chromosome 20. Upon digestion of 
genomic DNA with the restriction enzyme, EcoRI, an 
approximately 1.7 kb fragment is revealed by Southern blot 
analysis. This fragment consists of eleven 171 bp monomers, 
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is present in 100-1000 copies per genome, and hence covers a 
stretch of approximately 200-2000 kb (Oncer Inc., unpublished 
results). 
Bifunctional Alkylating Agents 
Nitrogen mustard was one of the first non-hormonal 
compounds to show clinical efficacy in the treatment of human 
cancer, and still is clinically used today (Figure l)(Goodman 
et al. 1946). The biological activity of this compound is due 
to the presence of the bis-(2-chloroethyl) group. A number 
of derivatives of this initial compound have been synthesized 
in which the methyl group has been replaced by a wide variety 
of carrier molecules, and many of these have found a niche in 
cancer chemotherapy. Some of these compounds have been 
examined in this dissertation, namely HN2, L-PAM, and two 
forms of cyclophosphamide which do not require metabolic 
activation: 4-S-(propionic acid)-sulfidocyclophosphamide (C2) 
and 4-hydroperoxy-cyclophosphamide ( 4H-C) (Hirano et al. , 
1979, Takamizawa et al., 1975). 
These agents are extremely reactive electrophilic 
compounds, which alkylate a number of cellular macromolecules 
including protein and RNA, but it appears that they exert 
their cytotoxic effects by producing lesions in the DNA 
(Johnson and Rudden, 1967, Rudden and Johnson, 1968, Lawley 
and Brooks, 1963, Erickson and Zlotogorski, 1984, Brooks and 
Lawley, 1965, Kohn et al., 1966). Alkylation of the DNA 
4-S(Proplonlc Acld)-Sutfidocyclophoaphamide 
(C-2) 
Nitrogen mustard 
(HN2) 
4-Hydroperoxycyclophoaphamlde 
(4-HC) 
Melphalan 
CL-Pam) 
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Figure 1. The chemical structures of Hli2, L-PAM, 4-HC, and 
C-2. 
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occurs primarily at the N7 position of guanine, and results 
in the formation of monoadducts, as well as DNA intrastrand 
and interstrand crosslinks. Studies using derivatives of the 
nitrogen mustards which were only capable of forming 
monofunctional adducts in the DNA demonstrated that while 
these compounds were mutagenic, they were not effective anti-
tumor agents compared to those compounds capable of forming 
interstrand crosslinks (Colvin, 1982). These observations 
have stimulated considerable interest in understanding the 
chemical nature of the bifunctional adducts and the subsequent 
biological consequences of this DNA damage. 
Brooks and Lawley first demonstrated mustard compounds 
could form cross links in DNA by isolating di ( guanin-7-yl) 
derivatives from cells treated with sulfur mustard (Brooks and 
Lawley, 1961). The bifunctional alkylating agents also form 
DNA interstrand crosslinks through covalent bonding at the N7 
position of guanines on opposite strands of the DNA. The DNA 
interstrand crosslink is an infrequently occurring lesion in 
cells treated with nitrogen mustards. Only 100-1000 
interstrand crosslinks are thought to be formed in cells 
following cytotoxic exposures to nitrogen mustards (Kohn et 
al., 1981). Nevertheless, the DNA interstrand crosslink has 
been strongly correlated with nitrogen mustard-induced 
cytotoxicity. Mechanistically, it has been hypothesized that 
the DNA interstrand crosslink inhibits DNA replication, by 
preventing strand separation, which ultimately leads to cell 
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death (Brooks and Lawley, 1965). Additionally, preventing 
strand separation may theoretically inhibit RNA transcription. 
Recent work supporting this possibility demonstrated that 
chloramphenicol acetyl transferase (CAT) expression vectors 
exposed to HN2 displayed a concentration-dependent increase 
in DNA interstrand crosslinks and a concommitant decrease in 
CAT expression (Dean et al., 1988). These experiments did not 
rule out the possibility that the decreased CAT expression was 
not the result of some other lesion. The molecular mechanisms 
of cellular repair of DNA interstrand crosslinks is not 
understood, but is probably a multi-step, multi-enzymatic 
process, similar to other DNA repair systems. 
Heterogeneous DNA Damage and Repair 
Many lines of evidence indicate that chemotherapeutic and 
carcinogenic DNA damaging agents interact with DNA in a non-
random fashion. Damage studies of carcinogens reacted with 
DNA in vitro indicate that differences exist at the primary 
sequence level (Hatley et al., 1986, D'Andrea and Haseltine, 
1978, Mattes et al., 1986, Bole and Hogan, 1984, Hurley et 
al. I 1985) • Moreover, other reports demonstrate that DNA-
damaging chemotherapeutic agents and carcinogens 
preferentially react with actively-transcribed genes, as well 
as with DNA-associated with the nuclear matrix where 
transcription and replication are thought to occur (Tew et 
al., 1978, Irwin and Wogan, 1984, Obi et al., 1986). 
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Although the production and disappearance of nitrogen 
mustard-induced DNA interstrand crosslinks in the entire 
genome has been well documented, the production and 
disappearance of DNA interstrand crosslinks within specific 
genes is unknown. Employing the rapid renaturation kinetics 
of crosslinked DNA, size fractionation of DNA by gel 
electrophoresis, and Southern blot analysis, it has been 
possible to detect DNA interstrand crosslinks in defined 
genomic restriction fragments (Vos and Hanawalt 1987). 
Using this type of experimental approach, gene-specific 
DNA interstrand crosslinks produced by the chemotherapeutic 
agents, Mitomycin c, and 4-hydroxymethyl-4,5' ,8 
trimethylpsoralen plus ultraviolet A irradiation (PUVA) have 
been assayed. Using Mitomycin C to produce DNA interstrand 
crosslinks, human cell lines derived from persons with 
Fanconi's anemia removed interstrand crosslinks from their 
ribosomal RNA (rRNA) genes more slowly than cell lines derived 
from control individuals (Matsumoto et al., 1989). PUVA-
induced DNA interstrand crosslinks and monoadducts also were 
assayed in the dihydrofolate reductase (DHFR) gene of a 
methotrexate-resistant human cell line (VA2-6A3). The DNA 
interstrand crosslinks disappeared more rapidly than the 
monoadducts, suggesting different types of DNA lesions are 
processed with different repair kinetics (Vos and Hanwalt, 
1987). 
Using similar experimental approaches, UV-induced DNA 
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damage and repair of specific genes has been studied (Bohr et 
al.)· Results from studies examining UV-induced pyrimidine 
dimers have indicated that these lesions are preferentially 
removed from certain regions of the genome, or in other words, 
DNA repair is heterogeneous. Using UV repair-deficient 
Chinese Hamster ovary (CHO) cell lines, it was demonstrated 
that 24 hours after exposure to moderate doses of UV (<15% 
cytotoxici ty), 85% of the UV-induced lesions were removed from 
the actively-transcribed DHFR gene, while the overall repair 
of the entire genome was only 15% (Bohr et al., 1985). On the 
basis of these results, it was hypothesized that the relative 
resistance of rodent cell lines to UV irradiation was due to 
their ability to repair essential genomic regions. Using a 
rodent fibroblast cell line (Swiss mouse 3T3), studies also 
have shown that the active c-abl proto-oncogene is repaired 
faster than the silent c-mos proto-oncogene, suggesting that 
repair may be coupled to RNA transcription (Madhani et al., 
1986). In support of the possibility that DNA repair is 
coupled to RNA transcription, it has been recently reported 
that, UV-damage in the lac operon of E. Coli was 
preferentially removed from the transcribed strand of these 
genes when RNA transcription of these genes was induced, but 
repair of the two strands was about equal when the genes were 
not being actively transcribed. (Mellon and Hanawalt, 1989) 
From this body of evidence, it is possible to suggest 
that DNA reactive drugs may preferentially modify specific 
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regions of the genome, and the subsequent repair of the 
resultant lesions may be removed preferentially from specific 
portions of the genome. By delineating the heterogeneity, it 
may be possible to find specific genomic regions that are 
susceptible to drug attack and/or repair bypass. Ultimately, 
this may lead to the elucidation of genomic regions critical 
for DNA damage-induced cytotoxicity. 
MATERIALS AND METHODS 
~11 culture 
colo320 HSR was the cell line used in this study, and 
was purchased from American Type Culture Collection. The cell 
line was cultured in RPM! 1630 (Gibco, Grand Island, N.Y.) 
supplemented with 15% heat inactivated bovine calf serum 
(Hyclone Laboratories, Logan, Utah) 1 mM glutamine (Gibco), 
penicillin (50 U/ml), plus streptomycin (50 µg/ml, Gibco) at 
37° c I 95% 021 5% C02. These cells have a doubling time of 
approximately 24 hours and were passaged twice a week to 
maintain logarithmic growth. Cells were counted on a Coulter 
counter Model ZBI to determine cell number. 
Bifunctional Alkylating Agents 
HN2 and L-PAM were obtained from the Drug Development 
Branch of the National cancer Institute. HN2 and L-PAM were 
dissolved in sterile filtered 0.1 N HCl and maintained as a 
frozen stock solution. c-2 was kindly supplied by Prof. Dr. 
Helmut Ringsdorf, University of Mainz, Federal Republic of 
Germany. C-2 was dissolved in sterile phosphate buffer 
immediately prior to use. 4H-C was the generous gift of Dr. 
Michael Colvin, of The Johns Hopkins School of Medicine. 4-
HC was dissolved in sterile RPM! 1630 immediately prior to 
use. 4-HC and C-2 were used instead of cyclophosphamide 
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because of the need for cyclophosphamide to undergo 
microsomal activation. C-2 was used for all DNA sequencing 
studies because it could be dissolved in phosphate buffer and 
did not deterimentally effect PAGE. 4-HC was used for all 
experiments involving cells because it was more readily 
obtained, and because it is in clinical use. Both 4-HC and 
c-2 spontaneously decompose in vitro to 4-0H-cyclophosphamide; 
the same intermediate resulting from the microsomal activation 
of cyclophosphamide. 
Survival Assays 
To determine doses of the antineoplastic agents used in 
this study, soft agar colony survival assays were utilized. 
Exponentially growing Colo320 HSR cells were exposed to drug 
for one hour at 37° C. The cells were washed free of drug by 
centrifugal pelleting, resuspending the cells in an equal 
volume of warm media, pelleting the cells again, and finally 
resuspending in one volume of warm media. The cells then were 
counted, and serially diluted into tubes to give ranges in 
cell concentration from 10 2 to 105 per ml. One ml of control 
and drug treated cells were seeded into culture tubes 
containing 3 mls of media and noble agar (Difeo, Detroit, Mi.) 
to produce a semi-solid support in which the cells could form 
colonies. The final concentration of noble agar in the media 
was 0.1% (Chu and Fisher, 1968). Cells were allowed to grow 
undisturbed for two weeks, at which time the number of 
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colonies was scored. Colony forming efficiency of untreated 
control cells was typically 75%. Colony forming efficiency 
was defined as the [number of countable colonies formed per 
tube/number of cells seeded per tube] x 100. Percent survival 
was defined as the 
treated cells/number 
cells] x 100. 
General Methods 
[number of colonies formed 
of colonies expected from 
from drug 
untreated 
A number of general procedures, techniques, and solutions 
used in this dissertation were employed in the experimental 
protocols. These are fundamental to the general laboratory 
work, and merit description for the sake of completeness. 
These basic procedures are described below. 
A. Reagent Preparation 
Organic sol vents were often used in the isolation of 
nucleic acids, but need to be prepared properly before use. 
Phenol was purchased as a solid, and was liquefied by heating 
at 68°C. The anti-oxidant 8-hydroxyquinilone was added to the 
liquefied phenol to a final concentration of 0.1% (w/v), and 
the reducing agent 2-mercaptoethanol was added to a final 
concentration O. 2% (v/v). The phenol solution then was 
extracted sequentially with 1.0 M Tris, pH 8.0; 0.1 M Tris, 
pH 8. O; and finally O. 01 M Tris, O. 001 M ethylenediamine 
tetraacetic acid (EDTA), pH 8.0 (TE, 8.0). This procedure 
neutralizes the acidic phenol, and adequate neutralization was 
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ensured by checking the pH of the final aqueous extraction 
(TE). The pH of the aqueous phase was typically -7. 5. 
Another organic solvent used in nucleic acid preparation was 
sevag, which is a 24:1 (v/v) mixture of chloroform:isoamyl 
alcohol. 
Some compounds were deionized before use. Compounds such 
as those used in this dissertation project included 100% 
formamide and 7 M glyoxal. These compounds were deionized by 
mixing with RG 501-XS mixed bed ion exchange resin (Bio-Rad 
Laboratories, Richmond, Ca.) for one hour at room temperature. 
The sample:resin mixture ratio is 1:1. The mixed bed resin 
then was removed by filtering the solution through a 0.45 µm 
pore size filter. 
B. Plasmid Isolation 
DNA fragments utilized in the DNA sequencing studies and 
used as gene-specific probes in hybridization studies often 
were purified from a number of bacterial plasmids. Large 
scale plasmid preparations were employed to obtain large 
quantities of these fragments. Bacteria harboring these 
plasmids were grown overnight in Luria-Bertani broth (per 
liter: 10 grams Bacto-tryptone, 5 grams Bacto-yeast extract, 
and 10 grams NaCl) at 37° C in an orbital shaking bacterial 
incubator. 
The bacteria were lysed, and the nucleic acids were 
recovered by the SDS-lysozyme procedure (Maniatis et al., 
1982). Five hundred mls of bacterial culture were pelleted 
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at 3750 rpm (4000 x g) in the Beckman Model J-6M centrifuge 
at 4°C for 10 minutes. The pellet was washed once in lx PBS, 
pelleted, and resuspended in 10 ml of ice cold 10% sucrose, 
o.05 M Tris, pH 7.5. To this, 0.5 ml lysozyme (10 mg/ml) and 
2 ml of 0.25 M EDTA were added, the tubes were inverted and 
then incubated for 10 minutes on ice. Ten mls of 10% sodium 
dodecyl sulfate (SDS), and 1.5 ml of 5 M NaCl was added, and 
the lysate was incubated on ice for 1 hour. The bacterial 
debris was pelleted in thick-walled polycarbonate tubes by 
ultracentrifugation (Beckman Model L8-70M) in a Beckman Ti70.1 
fixed angle rotor at 30,000 rpm (83,000 x g) and 4°C for 30 
minutes. The aqueous layer was saved and extracted twice with 
an equal volume of phenol/sevag (1:1), and once with sevag 
alone. Phases were separated by centrifugation in the Beckman 
Model J-6M at 2370 rpm (1600 x g) at room temperature for 10 
minutes. Nucleic acids were precipitated by the addition of 
2.5 volumes of ice-cold non-denatured 95% ethanol. Nucleic 
acids were recovered by centrifugaton in a Sorvall RC-5B 
refigerated superspeed centrifuge (DuPont) using the ss-34 
rotor. Centrifugation runs are at 4°C for 30 minutes at 10,000 
rpm (10,000 x g). Nucleic acids were dried in the lyophilizer, 
resuspended in TE 8.0, and treated with RNAse (10 µg/ml) for 
1 hour at 37°C. Proteins were removed by extraction with 
organic solvents as described above. 
To separate supercoiled plasmid DNA from the linear 
bacterial chromosomal DNA, total DNA was centrifuged in 6 M 
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cscl, 0.8 mg/ml ethidium bromide gradients in the type 70.1 
rotor, for 48-60 hours at 45,000 rpm, 20° c. After 
centrifugation, the plasmid band was detected by brief 
irradiation with a hand-held 254 nm source, the tube was 
punctured with an 18 g syringe needle, and the plasmid DNA 
withdrawn. Ethidium bromide was removed by 5 extractions with 
isoamyl alcohol. The DNA was dialyzed against TE, pH 8. O, and 
precipitated with 0.1 volume 3 M sodium acetate and 2 volumes 
of ice-cold, non-denatured 95% ethanol. 
c. Nucleic Acid Quantitation 
Nucleic acids were quantitated by UV spectrophotometry. 
Absorbance measurements of an aliquot of the nucleic acid 
samples were taken at 260 nm and 280 nm. The absorbance of 
the solution at 260 nm is directly proportional to the amount 
of nucleic acid, and the 260/280 nm absorbance ratio is an 
approximation of the purity of the nucleic acid (Maniatis et 
al., 1982). Ideally, a ratio of 1.8 to 2.0 is desired. 
D. Agarose Gel Electrophoresis 
Agarose gels were used to assess the molecular weights 
of isolated DNA, the completion of restriction enzyme digests, 
separation of genomic restriction enzyme digests for Southern 
blot analysis, and for separating, sizing and checking the 
integrity of RNA molecules. Agarose concentrations ( O. 4-1. 2%, 
w/v) were selected depending upon the size and conformation 
of the DNA or RNA to be analyzed. Electrophoresis grade 
agarose (Seakem ME, FMC Marine Colloids) was dissolved in a 
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given electrophoresis running buffer by heating to boiling in 
a microwave oven. Unless otherwise noted, the running buffer 
for DNA gels was 0.089 M Tris, 0.089 M boric acid, 0.002 M 
EDTA, pH -8.3 (lx TBE buffer), and the running buffer for RNA 
The molten agarose 
solution was cooled to 50 degrees, and cast in either a BRL 
"Babygel" or "H4" apparatus or the FMC "Resolute" apparatus. 
The gel was allowed to solidify for 30 minutes, and then 
submerged in electrophoresis running buffer. 
Aqueous DNA samples were mixed with a lOX loading 
buffer (50% glycerol, 0.25% bromphenol blue) and loaded into 
preformed wells, and electrophoresed at 1-15 volts/cm 
(distance between the electrodes). Molecular weight standards 
utilized included intact lambda phage DNA, lambda phage DNA 
digested with HindIII, 123 bp ladder (BRL), or the supercoiled 
DNA ladder (BRL). To stain DNA in the gel, ethidium bromide 
was either included in the buffer at a concentration of 0.5 
µg/ml, or the gel was stained with this solution following 
electrophoresis. DNA was then visualized and photographic 
records of the gel were made using a Fotodyne UV-440/Polaroid 
MP-4 photographic transilluminator system. 
The secondary structure of RNA must be removed to 
accurately size RNA molecules (Lehrach et al., 1977). Total 
cellular RNA samples were denatured by heating at 50°C for 1 
hour in a mixture of 50% dimethyl sulf oxide ( DMSO) , lM 
deionized glyoxal, o. 01 M sodium phosphate, pH 6. 8. The 
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samples were chilled on ice, 1/6 volume of a 40% sucrose, 
o.25% bromphenol blue loading dye was added, and the sample 
then was loaded onto the gel. The RNA was electrophoresed for 
20 minutes to allow the RNA to enter the gel, at which time 
a Manostat ministaltic pump was turned on to recirculate the 
buff er during electrophoresis which prevents the formation of 
pH gradients in the gel. Electrophoresis was carried out at 
3-5 volts/cm. Molecular weight markers were the 18 and 28 S 
rRNA bands. After electrophoresis, the marker lanes were cut 
off the gel and were de-glyoxalated by soaking the gel marker 
lanes in 0.05 M NaOH for 30 minutes at room temperature. The 
gel marker lanes then were rinsed with water, and stained with 
0.5 µg/ml ethidium bromide in 0.012 M Tris, 0.006 M sodium 
acetate, 0.0003 M EDTA (lx TAE). Photographic records were 
made as described above. 
It is possible to calculate the size of any nucleic acid 
fragment, whether detected by hybridization to radioactive 
labelled gene-specific probes used in blot hybridizations, or 
detected by ethidium bromide staining the nucleic acids 
directly in the agarose gel. Linear, double-standed DNA 
molecules, or denatured single stranded RNA molecules migrate 
through the gel matrix at rates that are inversely 
proportional to the log10 of their size (Helling et al., 1974). 
By plotting the log10 of the nucleic acid size markers in base 
pairs (bp) versus the distance migrated a linear relationship 
is observed. Thus, by knowing the distance migrated of any 
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nucleic acid fragment, and comparing it to the relative 
migration of a known set of nucleic acid size markers, it is 
possible to calculate the size of any sample in bp. 
E. Gel Purification of DNA Fragments 
Target DNA fragments were separated on agarose gels as 
described. Lanes included a single wide preparative lane, and 
two narrow marker lanes to the outside of the gel. After 
electrophoresis for appropriate separation of the target 
fragment(s) away from other DNA fragments, the target DNA was 
recovered using a combination of trough electroelution and 
electrophoresis onto a dialysis membrane. This procedure 
involved cutting a rectangular trough ahead of the band of 
interest, and inserting a piece of dialysis membrane over the 
forward surface of the gel, down the front wall of the trough, 
along the bottom of the trough, and under the back of the gel. 
The trough is filled with buffer and the DNA fragment 
electrophoresed through the trough and onto the dialysis 
membrane. The polarity of the gel was reversed for 1 minute 
to electroelute the DNA off the membrane. The buff er 
containing the DNA was removed, transferred to a 1. 5 ml 
microfuge tube and extracted (1:1) sequentially with phenol, 
phenol/sevag, and sevag. The DNA in the recovered aqueous 
phase was then precipitated with O .1 volume of 3 M sodium 
acetate and 2 volumes of ice cold, non-denatured 95% ethanol. 
The recovered DNA was collected by centrifugation at top speed 
at 4°C for 30 minutes in a Beckman Model 11 microfuge. The 
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DNA was resuspended in deionized water and purified of any 
contaminants using a Elutip nucleic acid purification 
cartridge (Schleicher and Schuell, Keene, N.H.) following the 
manufacturer's instructions. 
F. Nucleic Acid Blotting 
Following separation by agarose gel electrophoresis, 
nucleic acids were transferred to a filter support membrane 
by a process known as nucleic acid blotting. The filter 
membrane then can be probed for specific nucleic acid 
sequences by using radiolabelled nucleic acid probes 
complementary to a specific sequence of interest. Many 
procedures are available, and the one used in this 
dissertation project is described below. The transfer of both 
DNA and RNA to filter membranes was performed essentially as 
described (Southern, 1975). The nucleic acids were 
transferred to Genescreen plus nylon membranes (NEN Research 
Products, Boston, Ma.) by capillary action using lOX standard 
saline citrate (SSC) as the transfer solvent (lx SSC is 0.15 
M NaCl, 0.015 M trisodium citrate, pH 7.0). Briefly, a piece 
of Whatman 3MM paper was laid across a smooth solid support, 
which was placed above a tray containing lOX SSC. The piece 
of JMM paper had both of its ends in the lOX SSC, and served 
as a wick to allow for the lOx SSC to act as a transfer 
solvent. The gel was laid upside down on the Whatmann 3MM 
paper and care was taken to remove any air bubbles between the 
3MM paper and the gel. Next, the nylon membrane, cut to the 
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size of the gel, was carefully laid on the gel such that the 
nucleic acid binding side (side "B") of the filter was in 
direct contact with the gel. Again, care was taken to remove 
any air bubbles between the gel and the nylon membrane. 
sequentially added on to the top of the membrane were: five 
pieces of 3MM paper cut to equal size, a stack of gel blot 
paper (GB004, Schleicher and Schuell, Keane, N.H.), a glass 
plate, and a weight of -500 to 700 g. Before transfer of DNA 
or RNA, Genescreen plus nylon membranes were prepared for 
blotting. First, the membranes are wetted with deionized 
water for one minute and then lOx SSC for fifteen minutes. 
Immediately following nucleic acid transfer, membranes with 
RNA were immersed first in 0.05 M NaOH for 15 seconds and then 
0.2 M Tris, pH 7.5, lX SSC for 35 seconds. Membranes with 
transferred DNA were immersed first in O. 4 N NaOH for 45 
seconds, and then 0.2 M Tris, pH 7.5, 2X SSC for one minute. 
Transfer of the nucleic acids to the membrane was visualized, 
and therefore assured, by briefly irradiating the filter with 
254 nm light. 
G. Hybridization Probes 
A number of gene-specific probes were used in the 
analysis of northern and Southern blots. These probes were 
as follows: the 420 bp PstI exon 2 fragment of the human c-
myc oncogene (Figure 2), the 1 kb PstI fragment of the viral 
fos oncogene (v-fos)(Figure 2), a 350 bp HindIII fragment 
containing exon 1 of the human N-ras oncogene (Figure 2), and 
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a 770 bp fragment of a chicken cDNA encoding ~-act in. 
Additionally, a 1.7 kb probe for a-satellite DNA was used in 
southern blot analysis. Thep-actin and a-satellite probes 
were purchased as aqueous DNA solutions from Oncor, Inc. 
(Gaithersburg, Md.). The oncogene probes were isolated from 
plasmids originally purchased from ATCC (Colby et al., 1983, 
Curran et al., 1982, Taparowsky et al., 1983, Cleveland et 
al., 1980, Willard, 1987). 
H. 32P-Labelling of Hybridization Probes 
Radiolabelling of the DNA probes from these gene-specific 
probes was done by utilizing the random primer protocol. 
(Feinberg and Vogelstein, 1983, 1984). In this protocol, the 
fragment to be used as a probe was released from the vector 
in which it was contained, by restriction enzyme digestion. 
Using a low gelling temperature agarose (Sea Plaque LE, FMC) 
known amounts of the DNA fragments were separated by 
electrophoresis, using 0.04 M Tris-acetate, 0.005 M sodium 
acetate as the electrophoresis buffer. The buffer contains 
O. 2 µg/ml of ethidium bromide to visualize the DNA. The 
desired band was cut out of the gel and placed into a 
preweighed 1.5 ml microfuge tube. Deionized water was added 
to a ratio of 3 ml water to 1 gram of gel. The tube 
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Figure 2. Maps of plasmids containing the restriction 
fragments used as probes for nucleic acid hybridization 
assays. The relevant restriction sites and the regions used 
as hybridization probes are noted. 
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containing the DNA was boiled for 7 minutes to melt the gel 
and denature the DNA, and then stored for subsequent use at -
20°C. 
The labelling reactions are carried out using the Prime-
a-Gene labelling kit ( Promega, Madison, Wi.) and a- 32P dCTP 
(NEN specific activity 3000 ci/mmol). Briefly, target DNA was 
boiled for 3 minutes to remelt the agarose and denature the 
DNA, and 25 .to 40 ng of the DNA was added to the labelling 
reaction mixture. This mixture consisted of random sequence 
hexadeoxyribonucleotides, acetylated bovine serum albumin, 
nonradioactive dTTP, dGTP, dATP, and 50 µci of a-32P dCTP. 
After the addition of the denatured target DNA, 4.5 units of 
the Klenow fragment of E. Coli DNA polymerase I was added. 
Radiolabelled probe DNA was synthesized because the random 
hexamers hybridize to the single-strand target DNA, and serve 
as primers for the synthesis of new DNA by the enzymic action 
of Klenow fragment. 
Following a reaction time of 2 to 4 hours at room 
temperature, the polymerization reaction was stopped by the 
removal of unincorporated nucleotides by Sephadex G-50 gel 
filtration. G-50 
Boehringer Manheim 
quick spin columns were purchased from 
(Indianapolis, In.), and used following 
the manufacturer's instructions. Levels of incorporation were 
monitored by trichloroacetic acid (TCA) precipitation. 
Specific activity of the probes generated was typically 0.7 
to 1.0 x 109 cpm/µg DNA. 
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I. Quanti ta ti on of Incorporation of 32P into DNA Probes 
The level of radioactivity incorporated into DNA probes 
was measured by trichloroacetic acid precipi ta ti on. One 
percent of the labelled probe was added to 25 µg of yeast 
transfer RNA and the nucleic acids were precipitated by the 
addition of 1 ml of cold 10% TCA and placed on ice for 10 
minutes. The nucleic acid precipitate then was layered onto 
a Whatman GF/C glass fiber filter wetted with 10% TCA and 
positioned in a vacuum manifold (Millipore Bedford, Ma.). 
The tube was rinsed with cold 2% TCA, vortexed, and also 
layered onto the filter. Finally, the filter was washed with 
95% ethanol, and placed in a scintillation vial. Eight ml of 
scintillation fluid (Ready Gel, Beckman) were added to the 
vial containing the filter, and the sample was counted in a 
Beckman Model LS 5800 liquid scintillation counter. 
J. Nucleic Acid Filter Hybridization 
Prehybridization of the membrane was done in an effort 
to minimize non-specific binding by the radiolabelled nucleic 
acid probe. For all probes, except the a-satellite DNA probe, 
the membrane was pre-hybridized by incubating in 50% 
formamide, 10% dextran sulfate, 5X SSPE (lx SSPE is 0.15 M 
NaCl, 0.01 M dibasic sodium phosphate, and 0.001 M EDTA, pH 
7.4), 250 ug/ml denatured salmon sperm DNA, 1% sodium dodecyl 
sulfate (SDS), and O.lX Denhardt's solution (0.002% Ficoll 
400, O. 002% polyvinylpyrrolidone, O. 002% bovine serum albumin, 
Pentax Fraction V) at 42°C for 4-24 hours in a shaking water 
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bath. The filter pre-hybridization for the a-satellite probe 
was exactly the same as described above, except the salt 
concentration was reduced from 5X SSPE to 3X SSPE. 
Hybridization was carried out in the same pre-hybridization 
buffer to which approximately 1 million cpm/ml of 3~ labeled 
single stranded DNA probe had been added, for 18-24 hours at 
42 ° C in a shaking water bath. After hybridization the 
membrane was washed once in 250 ml of 2X SSPE containing 0.1% 
sos for 45 minutes at room temperature on a rocker platform. 
Except for filters hybridized with the v-fos probe, the 
membrane was then washed in a Disk Wisk membrane washer 
(Schleicher and Schuell, Keene, N.H.) in O.lX SSPE at 60 to 
65 °C for 6.5 minutes. Filters probed for c-fos sequences 
received a final wash as described above, except 0.2X SSPE was 
substituted for O.lX SSPE. After washing in the Disk Wisk, 
the membrane was blotted to dampness with Whatman 3 MM paper, 
heat sealed in plastic bags, and autoradiographed at -70°C for 
appropriate times. 
K. Autoradiography 
Detection of 32P labelled nucleic acids on filter 
membranes, agarose gels, or DNA sequencing gels was achieved 
by autoradiography. Gels were wrapped in Reynold's plastic 
wrap and filter membranes were heat-sealed in plastic bags 
before exposure to X-ray film. In the darkroom, the sample 
was placed in an X-ray film holder and covered with one or two 
pieces of x-ray film. The X-ray film used was either Kodak 
x-omat AR or DuPont Cronex 10. 
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The Kodak film was 
approximately four to five times faster than the DuPont film. 
Further increases in the sensitivity or speed of the film was 
accomplished by the use of either one or two calcium-
tungstate-phosphor intensifying screens (DuPont Cronex 
Lightning-Plus). Films were exposed to x-ray film with or 
without screens at -70°C for various periods of time (hours 
to days) . Films were developed in earlier experiments by 
hand, and in later experiments by an automatic X-ray film 
processor. 
L. Densitometry 
Estimations of relative amounts of nucleic acids detected 
by autoradiography were determined by densitometry. 
Autoradiographs were scanned on an LKB Ul troscan XL laser 
densitometer attached to an Epson FX-86e printer. Integration 
of the autoradiographic signals (area under the curve) was 
calculated by the densitometer, and relative amounts of 
nucleic acid were calculated. Efforts were made to scan at 
least two separate autoradiographic exposures from each 
individual experiment. Finally, due to the loss of linearity 
of the x-ray film, scanning overexposed autoradiographs was 
avoided (arbitrary absorbance units >2.5). 
M. Filter De-Probing (Stripping) 
Often filter membranes were stripped of the first 
hybridization probe to allow for a second hybridization of the 
same filter. Only membranes that remained damp can be 
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successfully stripped, hence the use of heat sealed bags for 
storage and autoradiography. Filters were stripped by 
immersing in a solution of TE, pH 7.5, 1% SDS heated to 90 to 
100°c. The filters were heated in this solution for 30 to 40 
minutes, then removed and blotted to dampness with Whatman 3 
MM paper. The stripped filter then was autoradiographed to 
ensure complete removal of the probe. 
Isolation of Total Cellular RNA and Measurement of Gene-
specif ic mRNA 
To minimize the activity and presence of RNAses, certain 
precautions were taken. Sterile, disposable plasticware was 
used whenever possible. Gloves were worn whenever tubes 
containing RNA were handled, or whenever solutions used for 
RNA preparation were handled. All solutions (except the 
guanidium lysis solution and ethanol) used for RNA preparation 
were treated with 0.1% diethyl pyrocarbonate for at least 12 
hours at 37°C, followed by removal of the diethyl 
pyrocarbonate by autoclaving. Solutions were then sterile 
filtered through a 0.2 µm pore size filter. 
The guanidium salt isolation procedure was used to purify 
total cellular RNA (Chirgwin et al., 1979). Control and drug-
treated cells (15 to 20 x 106 ) were pelleted by centrifugation 
in a Beckman Model TJ-6 table top centrifuge at 1800 rpm (800 
x g) for 5 minutes at room temperature. The media was poured 
off and the cell pellet was washed with ice-cold phosphate 
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buffered saline (PBS). The cells were centrifuged and washed 
again in lx PBS. The cell pellet was resuspended in 3.5 ml 
of a filtered ( O. 45 µm pore size) 4 M guanidium 
isothiocyanate, 0.02 M sodium acetate, 0.01 M dithiothreitol 
(OTT) , O. 5% Sarkosyl solution. The chromosomal DNA was 
sheared by repeated passage through a 20 gauge syringe needle. 
The lysate was then either quick frozen in a dry ice/ethanol 
bath and stored at -85°C or centrifuged immediately. For RNA 
isolation, the lysate was layered onto a 5.7 M CsCl, 0.1 rnM 
EDTA solution, and centrifuged in a Beckman SW-40Ti rotor at 
35,000 rpm (218,000 x g), 20°c, for 16 hours. The supernatant 
was aspirated off, and the RNA pellet was resuspended in 350 
µl of deionized water, transferred to a sterile 1. 5 ml 
microfuge tube, and precipitated with 0.1 volume 3 M sodium 
acetate and 2.5 volumes ethanol. The RNA was pelleted in a 
Beckman Microfuge 11 by centrifugation at 12,000 x g for 30 
minutes, at 4°C. The supernatant was removed, the RNA pellet 
was resuspended in a small volume of deionized water, and the 
RNA was quantitated by UV spectrophotometry. Equal amounts 
of total RNA isolated from control and drug-treated cells were 
size-fractionated by agarose gel electrophoresis, capillary 
blotted to nylon filter membranes, and probed for the 
expression of specific genes. 
DNA Interstrand Crosslinking Studies 
The induction and disappearance of nitrogen mustard-
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induced DNA interstrand crosslinks were estimated within the 
genome over al 1 and within specific genomic regions. These 
experiments were designed to first, determine if DNA 
interstrand crosslinks may be produced preferentially and/or 
removed from the transforming genes of human tumor cells, and 
second, to determine if DNA interstrand crosslinks may play 
a role in suppressing the production of mRNA transcripts from 
these genes. 
Measurement of Gene-Specific DNA Interstrand Crosslinks 
Gene-specific DNA interstrand crosslinks were measured 
using a DNA denaturation/renaturation gel electrophoresis plus 
Southern blot assay (Vos and Hanawalt 1987). With this 
technique, DNA isolated from drug treated and control cells 
was digested with a restriction enzyme, denatured under mild 
conditions and loaded onto a neutral agarose gel. The DNA 
restriction fragments that are crosslinked immediately 
renature and migrate as a double stranded molecule, but the 
non-crosslinked DNA migrates as single-stranded molecules. 
If the restriction enzyme used was chosen carefully, then an 
entire gene may be contained within a given fragment. 
Subsequent Southern blotting of the gel, followed by 
hybridization with a gene-specific probe allows for the 
detection of crosslinks within a specific gene. Furthermore, 
the frequency of gene-specific DNA interstrand crosslinks was 
calculated by densitometry by determining the fraction of 
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molecules migrating as a double- stranded molecule 
(crosslinked fragments) relative to the fraction migrating as 
single strand molecules (non-crosslinked fragments). 
If it is assumed that HN2 produces DNA interstrand 
crosslinks randomly, then the frequency of DNA interstrand 
crosslinks in a given DNA fragment can be calculated from the 
Poisson distibution: 
P x = ( mx I x ! ) x e-m 
where Px is the probability of X interstrand crosslinks, m is 
the mean number of crosslinks per fragment and e is the 
natural constant. The fragments with no interstrand 
crosslinks is P0 , and is the fraction of molecules that 
migrated as single-strand molecules. Conversely, the fraction 
of crosslinked fragments (fragments with one or more 
crosslinks which migrate as double-stranded molecules) 
corresponds to the complement of the zero class (l-P0 ). Thus, 
the mean number of crosslinks per fragment is -lnP0 (Vos and 
Hanawalt 1987). 
The nitrogen mustard-induced DNA lesion is a relatively 
unstable chemical adduct, and therefore efforts must be made 
to minimize the spontaneous degradation of this adduct, which 
can lead to a potential underestimation of DNA interstrand 
crosslinks. Earlier work (Kohn and Spears, 1967) demonstrated 
that the incubation of nitrogen mustard-crosslinked DNA in a 
0.05 M sodium carbonate solution of 10< pH <10.8 derivatizes 
nitrogen mustard-modified guanine bases to the formamido 
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pyrimidine form, and this form is essentially resisitant to 
spontaneous degradation. The exposure of DNA to nitrogen 
mustard can cause spontaneous depurination of modified bases. 
The use of the standard DNA denaturant, NaOH, therefore 
creates potential problems because NaOH is known to cause DNA 
strand breaks at apurinic sites. NaOH-induced strand breakage 
will cause a decrease in double-stranded DNA fragments, and 
thus a decrease in the estimation of gene-specific DNA 
interstrand crosslinks. 
In the present study, experiments were designed such that 
all cells from the various time points were lysed at the same 
time. This procedure obviated the concern that differential 
nitrogen mustard-induced spontaneous DNA degradation could 
occur, due to different periods of storage of the DNA from 
different time points. Another attempt to minimize drug-
induced, spontaneous DNA degradation is to assay the DNA for 
interstrand crosslinks within 24 to 30 hours from the time of 
the cell lysis. Finally, to avoid the concern that NaOH 
denaturation may cause strand breaks in DNA isolated from 
drug-treated cells, a milder denaturing procedure was used; 
DNA was incubated at 65°C for five minutes in the presence of 
65% formamide. 
A. Isolation of High Molecular Weight DNA 
Control and drug-teated cells ( 15 to 20 x 106 ) were 
pelleted by centrifugation in a Beckman Model TJ-6 table top 
centrifuge at 1800 rpm ( 800 x g) for 5 minutes at room 
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temperature. The media was poured off, and the cell pellet was 
washed with ice-cold phosphate buffered saline (PBS). The 
cells were centrifuged and washed again in lx PBS. 
Following the second wash the cell pellet was resuspended 
in 7 mls of a cell lysis buffer consisting of 0.05 M 
NaHCOjNa 2CQ31 o. 001 M EDTA, o. 5% N-Lauroyl Sarcosine (w/v), 
and O. 3 mg/ml proteinase K. The final pH of the lysis 
solution was 10.4, and was buffered well enough to maintain 
this pH throughout the cell lysis procedure. The cell lysate 
was incubated in a water bath at 37°C for 2 hours to ensure 
total cell lysis. 
The nucleic acids were separated from the cell lysate by 
standard organic solvent extractions. The lysate was 
extracted once with an equal volume of phenol saturated with 
TE, pH 8.0,, once with an equal volume of phenol/sevag (1:1), 
and once with an equal volume of sevag. The cell lysates were 
mixed with the organic solvents by gentle mixing for 5 to 10 
minutes. The aqueous phase was separated from the various 
organic phases by centrifugation in a Beckman J-6M centrifuge 
at 2370 rpm (1600 x g), at room temperature for 10 minutes. 
In each extraction the aqueous phase was removed from the 
organic phase with a wide bore pipette. Following the final 
organic extraction, the nucleic acids were precipitated by the 
addition of 0.2 volumes of 11 M ammonium acetate and two 
volumes of ice cold, non-denatured 95% ethanol. 
The precipitated nucleic acids were removed by spooling-
out with a pipette tip. 
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Excess salt was removed from the 
nucleic acids by washing the pellet with 70% non-denatured 
ethanol. The nucleic acids were then resuspended in three ml 
of deionized water for one hour at 37°C. RNA was removed by 
digestion with 10 ug/ml RNase A (Sigma St. Louis, Mo.) for 
one hour, at 37°C. Following RNase A digestion, the protein 
was removed by one phenol/sevag and one sevag extraction, as 
described above. The DNA was then precipitated by the 
addition of 0.1 volumes of 3 M sodium acetate and two volumes 
of ice cold non-denatured ethanol. 
The precipitated DNA was spooled-out and resuspended 
overnight in 350 µl of deionized water at 4°C. To document 
that the isolation of high molecular weight DNA, aliquots of 
individual samples were electrophoresed on 0.4% agarose mini-
gels in parallel with a known amount of intact lambda 
bacteriophage DNA. This allowed for the approximate 
determination of both the size and concentration of the sample 
DNA. DNA samples were used only if they are equal to, or 
larger than, the intact lambda phage DNA molecule (-49 kb). 
B. Restriction Enzyme Digestion of Genomic DNA 
The high molecular weight genomic DNA was then digested 
with a given restriction enzyme were done according to the 
manufacturer's specifications. The digestions were carried 
out for 2.5 to 3.0 hours at 37°C. At this time, complete 
restriction enzyme digestion was checked by electrophoresing 
an aliquot of each sample on a 0.8% agarose minigel. HindIII-
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digested lambda phage was used as a DNA size marker, and was 
electrophoresed in parallel with the digested samples. 
completely digested samples were extracted once with 
phenol/sevag and once with sevag. Phases were separated by 
centrifugation in a Beckman Model E microfuge for two minutes 
at top speed at room temperature. The DNA, recovered from the 
aqueous phase, was precipitated by the sequential addition of 
o.1 volume of 3 M sodium acetate and two volumes of ice cold, 
95% non-denatured ethanol. 
c. DNA Denaturation-Renaturation Gel Elctrophoresis and 
Southern Blot Analysis 
The precipitated DNA was collected by centrifugation in 
a Beckman Model 11 microfuge for 30 minutes at 4 ° c. The 
supernatant was removed, and the DNA pellet was washed with 
70% ethanol. The pellet was then dried in a Savant speed vac 
concentrator connected to a Virtis lyophilizer and a Precision 
vacuum pump. The dried DNA pellet was resuspended in a small 
volume of O. 01 M Na 2HP04 /NaH2P04 pH 7. O. Following 
spectrophotometric quanti ta ti on, the DNA samples were prepared 
for crosslinking analysis by agarose gel electrophoresis. Ten 
microgram samples of DNA isolated from control and drug 
treated samples were assayed by the DNA crosslinking gels. 
Samples were either electrophoresed as native, double-stranded 
DNA molecules, or were denatured immediately prior to loading 
onto the gel. DNA molecules that were not crosslinked migrate 
as single-stranded molecules, but those DNA fragments with 
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crosslinks immediately renature, and migrate as double-
stranded molecules. To DNA samples electrophoresed as native 
double-stranded molecules, 0.1 volume of a 50% glycerol, 0.25% 
bromphenol blue gel loading dye was added. To DNA samples 
electrophoresed as single stranded DNA molecules, two-thirds 
volume of a denaturing loading dye was added, and samples were 
denatured by heating at 65°C for five minutes, and quick-
chilled on ice prior to loading onto the gel. The DNA 
denaturing gel loading dye consists of 96% deionized 
formamide, 0.001 M EDTA, 0.1% bromphenol blue and 0.1% xylene 
cyanol. Native and denatured DNA samples were electrophoresed 
at 30 volts for 14 to 18 hours. Lambda phage DNA digested 
with HindIII was electrophoresed in parallel with the sample 
DNA, and served as a DNA size marker. The ethidium bromide-
stained DNA was visualized on the UV transilluminator, and a 
photographic record was made of each gel. A flourescent ruler 
was placed on the gel, next to the DNA size marker, and served 
as a measure of the relative mobility of the size marker 
fragments. 
Following gel electrophoresis of the DNA, the gel was 
prepared for Southern blotting. The gel was first immersed 
in 1 liter of 0.25 M HCl and slowly rocked on a rocking 
platform for 15 minutes at room temperature. This served to 
depurinate the DNA in the gel matrix. The HCl was aspirated 
away from the gel, and was replaced with a DNA denaturation 
solution for 30 minutes at room temperature on the rocking 
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platform. This solution was comprised of 0.5 M NaOH, 0.4 M 
NaCl, and was used to fully denature the DNA and hydrolyze the 
DNA at apurinic sites. This treatment facilitates the 
transfer of large DNA molecules out of the gel matrix. After 
the alkaline wash, the solution was aspirated away and 
replaced with a neutralization solution for one hour. The 
neutralization solution was comprised of 0.5 M Tris, pH 7.5 
and 3 M NaCl. During the post-electrophoresis gel treatments, 
the bromphenol blue and xylene cyanol in the gel loading dyes 
served as pH indicators, and their color changes are 
indicative that the solutions used penetrate the gel matrix. 
Bromphenol blue is yellow at acid pH, and blue at neutral and 
basic pH; xylene cyanol is blue at acid pH, and green at 
neutral and basic pH. Following the post-electrophoresis gel 
treatments, the DNA within the gel was to nylon membranes by 
capillary blotting, and probed for sequences as described 
earlier. 
Measurement of Genomic DNA Interstrand Crosslinks 
The production and disappearance of DNA interstrand 
crosslinks in the total genome was measured by the 
crosslinking assay of the alkaline elution technique (Kohn et 
al., 1981). Exponentially growing Colo320 HSR are labelled 
by the addition of O. 02 µCi/ml 14C-thymidine ( sp. act. 56 
mCi/mmol, NEN, Boston, Ma.) to their growth media for 24 
hours. This was followed by growth in radioactive-free media 
48 
for 24 hours prior to drug treatment. This "cold chase" 
allows for all the 14C label to be incorporated into long chain 
DNA. L1210 mouse leukemia cells, which were used as internal 
standards were labelled with 0.05 µCi/ml 3H-thymidine (sp. 
act. 20 mCi/mmol, NEN) 24 hours before use. L1210 cells have 
a doubling time of 12 hours, therefore the radiolabel was 
depleted from the media in the first 12 hours and the second 
12 hours acted as the chase period. 
Approximately 1.5 x 105 control, or drug-treated, Colo320 
HSR cells (14C) and 1.5 x 105 Ll210 cells ( 3H) were added to 
five ml of cold, complete media and irradiated with 300 rads 
of X-ray to introduce a fixed amount of DNA single strand 
breaks. The irradiated cells, which were kept on ice, were 
layered onto a 0.8 µm pore-size polycarbonate filter 
(Nucleopore, Ca.) using mild suction. The cells were 
immediately lysed with 2% SDS, 0.02 M EDTA, pH 10.0. DNA-
protein cross links were removed by Proteinase K treatment 
(0.5 mg/ml), after cell lysis and prior to elution. For the 
alkaline elution of the DNA, a tetrapropylammonium hydroxide 
(RSA Corp. Ardsley, N.Y.) solution containing 0.02 M EDTA, 
0.01% SDS, pH 12.1 was pumped through the filter at a rate of 
2 ml/hr for 15 hours by a Gilson Minipuls 2 peristaltic pump. 
Five 3. 0-hour fractions were collected, as was the liquid 
remaining in the lines or on the filter, and assayed for 
radioactivity by liquid scintillation counting using Beckman 
Ready Gel scintillation fluid and a Beckman LS 5800 liquid 
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scintillation counter. 
After the amount of radioactivity of each fraction was 
determined, the fraction of 14C retained on the filter was 
calculated and plotted on a double log scale against the 
fraction of 3H retained on the filter. Thus, the 3H-labelled 
L1210 cells serve as an internal control to monitor anomalies 
in pump speed and/or f i 1 ters. Increasing amounts of 14C 
retained on the filter relative to 3H are indicative of DNA 
interstrand crosslinks. Apparent DNA interstrand crosslink 
frequencies (in rad equivalents) are calculated using the 
following formula: 
DNA Interstrand Crosslinks = {[(1 - r 0 ) / (1 - r)] 112 - 1} x 300 
rads 
where r 0 and r are the fractions of the 14C-labelled DNA from 
drug treated and control cells remaining on the filter when 
25% of 3H-labelled DNA is retained on the filter (Kohn et al., 
1981) . 
Measurement of Colo320 HSR DNA Synthesis 
Experiments were performed to assess the effects of HN2 
on 3H-thymidine incorporation into the acid insoluble fraction 
of Colo320 HSR. This incorporation presumably reflects 
incorporation only into DNA (and not RNA) because thymidine 
was used. Initial experiments were performed to determine how 
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long cells maintain linear incorporation of the 3H-thymidine, 
after the addition of the radioisotope into the growth media. 
Exponentially-growing control Colo320 HSR cells (4 - 5 
x 10 5 cells/ml) were incubated with five µCi of 3H-thymidine 
per ml of cell culture. Two aliquots of 1 ml were taken after 
incubation at 37°C for 30, 60, 90, and 120 minutes, 
respectively. Cells in the aliquots were pelleted by 
centrifugation (as described above), the media was removed, 
and the cells were resuspended in five mls of ice-cold lx PBS, 
and placed on ice. The cells were then layered onto Whatman 
GF/C glass fiber filters, that had been previously wetted with 
ice-cold lx PBS and placed on a Millipore vacuum manifold. 
The cells were then lysed by the addition of 10 mls of ice-
cold 10% TCA, followed by 10 mls of ice-cold 2% TCA, and 
finally 10 mls of 95% ethanol. Filters were removed from the 
manifold, placed in scintillation vials, and dried for 15 
minutes in an 80 ° C oven. Eight mls of Beckman Ready Gel 
scintillation fluid were added and the samples were counted 
in the Beckman LS 5800 liquid scintillation counter. These 
experiments demonstrated that 3H-thymidine was incorporated 
into the DNA of exponentially-growing Colo320 HSR cells for 
at least 90 minutes after the addition of five µCi 3H-
thymidine per ml of growth media. 
To assess the effects of HN2 on DNA synthesis in 
exponentially growing Colo320 HSR, cells were exposed to 
varying concentrations of HN2 for one hour at 37°C, and washed 
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free of drug. Cells were resuspended in warm media and 800 
µ1 aliquots of cells were combined with 200 µl of warm media 
containing 5 µCi of 3H-thymidine. Another 500 µl sample was 
used to determine cell number. Cells were incubated for 60 
minutes at 37°C, and then assayed for TCA-precipitable counts. 
This is done three times after drug exposure: from O - 1 hour 
after drug removal; 2.5 - 3.5 hours after drug removal; from 
5 - 6 hours after drug removal. The 3H CPM in the TCA-
precipi table fractions was then determined. Values obtained 
for drug-treated samples were expressed as a percent of 
control corrected for differences in cell number. 
In vitro N7 Guanine Alkylation Studies 
A. Target DNA Preparation 
Cesium Chloride purified, pGEM-3Z 420 c-myc (-8) DNA 
(Figure 3) was digested with PstI and the products of the 
reaction are electrophoresed on a 1.2% agarose gel. The 420 
bp c-myc DNA fragment was eluted from the gel (as described 
above), and was 3' end-labeled by incubation (60 min, 37°C) 
with 15 units terminal deoxyribonucleotidyl transferase 
( Stratagene, La Jolla, Ca.) and 170 µci [ a-32P] ddATP ( 5000 
Ci/mmol; Amersham, Arlington Heights, IL) in a reaction buffer 
consisting of O .140 M sodium cacodylate, O. 001 M cabal t 
chloride, and 0.0001 M dithiothreitol, pH 7.5 (Yousaf et al., 
1984). Incorporation of the radioactive nucleotide was 
monitored by TCA precipitation. Following labelling and 
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Pst I Pst I 
pGEM-3Z 420 c-myc -8 
Figure 3. pGEM-3Z 420 c-myc +8 plasmid used for N7 
guanine akylation studies and Maxam and Gilbert DNA 
sequencing. Relevant restriction sites are noted. 
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ethanol precipi ta ti on, the DNA was digested with Sst II, 
resulting in 382 bp and 38 bp end labelled fragments. 
unincorporated nucleotide and the the labelled 38 bp fragment 
were removed by G-50 gel filtration. 
B. Chemical DNA Sequencing 
DNA sequencing of the 382 bp 3' end-labeled c-myc 
fragment was accomplished using the chemical sequencing 
technique. The reaction conditions and components to which 
end-labelled DNA are exposed was exactly as previously 
described (Maxam and Gilbert, 1980). Briefly, all base-
specific modification reactions are carried out at 15°C. The 
guanine-specific modification was carried out by the addition 
of 100% dimethyl sulfate (Kodak, Rochester, N.Y.) to a final 
concentration of O. 5% for seven minutes. Purine-specific 
modification was done by the addition of 90% formic acid 
(Sigma, St. Louis, Mo.) to a final concentration of 65% for 
12 minutes. Pyrimidine-specific modification was accomplished 
by the addition of 100% hydrazine (Aldrich, Milwaukee, Wi.) 
to a final concentration of 50%. Cytosine-specific 
modifications also was performed by the addition of hydrazine 
to a final concentration of 50%, but reaction with thymine was 
suppressed by the addition of NaCl to a final concentration 
of 1 M. After base modification, stop solutions were added 
and nucleic acids were precipitated with three volumes of ice 
cold, non-denatured 95% ethanol, and stored at -70°C for five 
minutes. The base-modified DNA was pelleted by centrifugation 
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at 4°C for 15 minutes in the Beckman Model 11 microfuge. The 
pellet was resuspended in 250 µl of ice cold 3 M sodium 
acetate, precipitated by the addition of three volumes of ice 
cold, non-denatured 95% ethanol, and stored at -70°C for five 
minutes. Base-modified DNA was collected by centrifugation, 
and the DNA pellet was washed free of residual salt by rinsing 
with 70% ethanol at room temperature. Strand breakage at 
sites of modified bases was achieved by incubation of the 
modified DNA with freshly-diluted 1 M piperidine (NEN, Boston, 
Ma.) at 90 ° C for 30 minutes. Piperidine was removed by 
lyophilization, and residual piperidine was removed by 
repeated washing of the pellet with deionized water and drying 
by lyophilization. 
c. Drug Treatment of 420 bp c-myc Fragment in vitro 
End-labeled, double-stranded DNA was added to TE pH 8.0 
(final volume 100 ul), and drugs were added to a final 
concentration of o, 12.5, or 25 µML-PAM; O, 2.5, or 5 µM HN2; 
and o, 50 or 100 µM activated C2. The reactions then were 
incubated for 1 hr at 37°C. Because L-PAM and HN2 were stored 
as a stock in O .1 N HCl, the pH was closely moni tared to 
ensure a reaction pH of -7 to 8. After drug incubation, 10 
ug tRNA and 0.1 volume of 3 M sodium acetate were added and 
nucleic acids were precipitated with three volumes of ice 
cold, non-denatured 95% ethanol, and stored at -70°C for five 
minutes. The drug-modified DNA was pelleted by centrifugation 
at 4°C for 15 minutes in the Beckman Model 11 microfuge. The 
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pellet was resuspended in 250 µ.l of ice cold 3 M sodium 
acetate, precipitated by the addition of three volumes of ice 
cold, non-denatured 95% ethanol, and stored at -70°C for five 
minutes. Drug-modified DNA was collected by centrifugation, 
and the DNA pellet was washed free of residual salt by rinsing 
with room temperature 70% ethanol. The drug-modified DNA 
pellet then was lyophilized to dryness and resuspended in 
freshly-diluted 1 M piperidine. Cleavage of DNA at alkylated 
N7 guanines was accomplished by incubating the drug-modified 
DNA in the 1 M piperidine at 90°C for 15 minutes (Mattes et 
al., 1986). Piperidine was removed by lyophilization, and 
residual piperidine was removed by repeated washing of the 
pellet with deionized water and drying by lyophilization. 
D. Polyacrylamide Gel Electrophoresis of DNA Damage and DNA 
Sequencing Products 
End-1abe1 ed , drug-treated , chemi ca 11y-c1 ea ved DNA, as 
well as DNA products from the guanine-specific (G), purine-
specific (G+A), pyrimidine-specific (C+T), and cytosine-
specific (C) reactions of the Maxam-Gilbert protocol, were 
resuspended in 3 µ.l loading solution (80% formamide, O.OlM 
NaOH, O.OOlM EDTA, 0.1% xylene cyanol, and 0.1% bromphenol 
blue), heated at 90°C for 3 minutes, and chilled on ice for 
1 minute. Approximately equal amounts from each group were 
loaded on a 6% denaturing polyacrylamide gel [acrylamide:bis-
acrylamide (19:1), 8.3 M urea, in lx TBK] and were 
electrophoresed for 3 hours at constant power ( 50 watts) . The 
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duration of electrophoresis eliminated any DNA fragments 
derived from the end-labeled 38 bp Sst II-Pst I DNA fragment 
that were not removed by G-50 gel filtration. This resulted 
in adequate separation of end-labeled DNA fragments derived 
from the DNA region 60-200 nucleotides 5' to the labeled end 
of the 382 bp fragment. Following electrophoresis, the gel 
was dried under vacuum at 80°C on a Bio-Rad Model 483 slab 
dryer, and autoradiographed for appropriate periods of time 
at -70°C. 
RESULTS 
Effect of Nitrogen Mustard Exposure on Colo320 HSR Viability 
Bifunctional alkylating agents are used clinically for 
their cytotoxic action. For this reason, in studies conducted 
in the context of this dissertation, drug exposures were 
chosen for their ability to reduce Colo320 HSR viability by 
at least 90%. Viability (or clonogenic survival) was measured 
by the use of the colony formation assay. 
Initial attempts to use the colony formation assay were 
not successful. Untreated Colo320 HSR cells had a colony 
formation efficiency of only 10% ([cells that formed 
colonies/cells seeded] x 100). Colo320 HSR cells, capable of 
efficient colony formation in soft agar, were therefore 
selected by resuspending one of the colony-containing agar 
tubes in fresh media. Cells that grew from this initial 
seeding were cultured, and tested again for their ability to 
form visible colonies in soft agar. 
These selected Colo320 HSR cells had a colony forming 
efficiency of approximately 75%. Thereafter, these "agar 
growing" Colo320 HSR cells were cultured. Aliquots of these 
cells were frozen in liquid nitrogen ( cryovials labelled 
Colo320 HSR-A), and used for all subsequent studies. 
The effects of bifunctional alkylating agents exposure 
on viability in exponentially-growing Colo320 HSR (treated at 
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4-5 X 105/ml) were determined. 
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The drug concentrations 
examined for L-PAM were from O - 35.4 µM, HN2 concentrations 
from O - 10 µM, and 4-HC concentrations from O - 100 µM. 
Figure 4 illustrates the concentration-dependent relationship 
between bifunctional alkylating agent concentration and 
colo320 HSR viability. One hour exposure to 2.1 µM HN2, 12.5 
µM L-PAM, and 40 µM 4-HC were approximately equitoxic and 
produced slightly greater than a one log cell kill ( 10% 
survival). The three log cell kill drug concentrations were 
6.3, 25, and 80 µM for HN2, L-PAM, and 4-HC, respectively. 
These were the minimal exposures used for the studies 
described below. 
In vitro Alkylation of N7 Guanine by Bifunctional Alkylating 
Agents 
The N7 position of guanine in DNA is thought to be the 
critical site of reaction in the cell, its being the precursor 
to the cytotoxic DNA interstrand cross link. These experiments 
were performed to determine the extent of alkylation of the 
N7 position of guanine in DNA by exposure to the bifunctional 
alkylating agents. This experimental approach allowed for the 
determination of potential differences or preferences of DNA 
sequence reactivity between the bifunctional alkylating 
agents. 
The double-stranded 420 bp fragment of exon 2 of the c-
myc oncogene was 3' end-labelled with 32P-ddATP, and the DNA 
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Figure 4. Colony formation ability of Colo320 HSR cells 
exposed to varying concentrations of HN2, L-PAM, and 4-HC for 
one hour at 37°C. Cells were washed free of drµg, seeded into 
agar tubes, and colonies were scored 14 days \ater. Points 
and verticle bars are the means and standarq ·deviations of 
three independent experiments. 
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fragment was exposed in vitro to 2.5 and 5.0 µM HN2, 12.5 and 
25 µM L-PAM, or 50 and 100 µM C-2 for one hour at 37°C. The 
drug was removed, and the DNA was cleaved at sites of N7 
alkylation by incubation with piperidine at 90 ° c. The 
resulting cleaved DNA fragments were electrophoresed in 
parallel with standard Maxam and Gilbert sequencing reactions. 
This allowed for the delineation of specific nucleotides 
attacked by the respective bifunctional alkylating agents 
along a portion of the sense strand (protein coding strand) 
of the c-myc gene. The autoradiograph of a representi ve 
experiment is shown in Figure 5. This figure illustrates the 
ability of the bifunctional alkylating agents to potentially 
attack any guanine nucleotide along the DNA template. It also 
is possible to get an indication of the relative reactivity 
of the bifunctional alkylating agents, based upon the amount 
(inferred from the autoradiographic signal) of full-length DNA 
molecules at the top of the gel because full length molecules 
indicate DNA that was not attacked by drug. Figure 6 shows 
an expanded view of the boxed area of Figure 5. This figure 
illustrates the sequence of the DNA template and the sites of 
N7 guanine alkylations from 106 to 131 nucleotides located 5' 
from the labelled 3' end of the c-myc sense strand. Clearly, 
every guanine in this tract was alkylated and no overt 
sequence specificity was discerned, however, differences did 
exist in overall reactivity of the drugs (L-PAM > HN2 > C-2). 
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Figure 5. N7 guanine alkylations produced by C-2, HN2, and 
L-Pam in vitro. The 3'-end labelled 420 bp fragment c-
myc exon 2 fragment was exposed to either 50 and 100 µM C-2, 
2.5 and 5.0 µM HN2, or 12.5 and 25 µM L-PAM for one hour at 
37°C. The drug-treated, end-labelled DNA was then cleaved at 
sites of N7 guanine alkylation by incubation with 1 M 
piperidine (90°C, 15 minutes). The resultant products then 
were electrophoresed in parallel with the standard Maxam and 
Gilbert DNA sequencing reactions (G, A+G, C+T, and C) on a 6% 
denaturing polyacrylamide gel. Following electrophoresis, the 
gel was vacuum-heat dried and autoradiographed. 
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Figure 6. Panel A) The boxed area in Figure 5 has been 
enlarged to more clearly indicate the DNA fragments cleaved 
at sites of N7 guanine alkylations. Panel B) Above is the 
DNA sequence of the region of the gel that could be resolved, 
and the boxed area is the portion of the sequence that has 
been enlarged in panel A. 
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Gene Expression studies 
Experiments were designed to test: 1) if bifunctional 
alkylating agents depress the steady state expression of 
proto-oncogene(s)/oncogene(s); and 2) if the three 
stucturally-related compounds differ in their ability to 
elicit these changes. 
Colo320 HSR cells were exposed, for one hour, to two 
concentrations of drug that produced one and three log cell 
kills. The drug was removed and the cells were resuspended 
in fresh media. Total cellular RNA was isolated from drug-
treated cells immediately after drug removal (O hour), and 
again 6, 12, and 24 hours after drug removal. Control total 
cellular RNA was obtained from untreated Colo320 HSR cells at 
the o hour time point. During the 24 hour time course, cell 
number was monitored. Drug-treated cell growth ceased; less 
than 20% increase in cell number was observed in any drug-
treated sample. Approximately equal numbers of cells were 
lysed for total cellular RNA isolation at each time point. 
The effect of nitrogen mustard exposure on the steady 
state expression of specific genes was assayed by Northern 
blot analysis. Relative amounts of gene-specific mRNA from 
drug-treated cells after drug removal were compared to mRNA 
levels in untreated, control cells. Equal amounts of total 
RNA from each sample were denatured with glyoxal and 
electrophoresed. Size-fractionated RNA was transferred by 
capillary action to nylon membranes, and hybridiz~d with a 32P-
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labelled DNA probes specific for either c-myc, c-fos, N-ras, 
or p-actin mRNA. Following autoradiography of the hybridized 
filter, it was possible to get a reliable assessment of the 
relative amounts of specific mRNA in the respective samples, 
based on the signal intensity produced by the hybridized, 
labelled probe. 
Precautions were taken to ensure reliable estimations of 
relative mRNA levels. From the outset, RNA quantitation must 
be precise and equal amounts of RNA must be carefully loaded 
onto the gel prior to electrophoresis. These manipulations 
were checked periodically. For an indication of RNA integrity 
and equality of RNA loading on the gel, RNA was 
electrophoresed, stained with ethidium bromide in the gel, and 
visualized by UV. Figure 7 is an example of such a gel. 
Colo320 HSR cells were treated with either 12.5 or 25 µM L-
PAM, and equal amounts (20µg/lane) of RNA from control and 
drug-treated cells were electrophoresed and stained. 
Examination of the 18s and 28s rRNA in the samples 
demonstrates that the RNA was intact and essentially equal 
amounts of RNA were loaded and electrophoresed. Additionally, 
after capillary blotting of the RNA, the homogeneity of 
transfer, integrity of the RNA and equality in gel loading was 
further checked by the visualization of transferred, filter-
bound RNA with UV light. 
To measure quantitatively signal intensity on 
autoradiographs, the concentration of the labelled probe in 
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the hybridization solution must be in excess with respect to 
the complementary target sequence on the filter. Otherwise, 
real differences in relative mRNA levels may not be observed. 
Experiments were conducted to determine if the probe 
concentration was in excess of the filter-bound sequences, 
under the hybridization conditions used in this study. 
Incremental amounts of Colo320 HSR total cellular RNA 
were electrophoresed, transferred, and hybridized to 32P-
labelled probes specific for c-myc or N-ras. Figure 8 
represents an autoradiograph of a filter with 5, 10 or 20 µg 
of transferred, Colo320 HSR RNA per lane hybridized to a 32P-
labelled c-myc probe, under the hybridization conditions used 
in all subsequent experiments. Quantitation of the 
autoradiograhic signal by scanning laser densitometry 
indicates that the c-myc probe is in excess of filter-bound 
c-myc mRNA contained in at least 20 µg of total cellular 
Colo320 HSR RNA (figure 8b). Figure 9 is a picture of an 
autoradiograph of a filter with 20, 40, 60, or 80 µg of 
transferred Colo320 HSR RNA per lane hybridized to a 32P-
labelled N-ras probe, under the hybridization conditions used 
in all subsequent experiments. Densitometry of this 
autoradiograph indicates that N-ras probe is in excess of 
filter-bound N-ras mRNA contained in at least 80 µg of total 
cellular Colo320 HSR RNA. 
Figure 10 shows the effects of L-PAM, 4-HC, and HN2 on 
c-myc steady-state transcripts, as measured by Northern blot 
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analysis. Each agent produced an initial increase in c-myc 
transcripts immediately following drug removal. Densitometric 
measurements of each autoradiograph indicate this to be an 
approximate 2 - 3 fold increase in steady state transcripts 
of this highly overexpressed gene. At 6 and 12 hours after 
drug removal, c-myc transcripts consistently were reduced 
following drug exposures which produced 1 and 3 log cell 
kills. These exposures produced approximately 2.5 and 5-fold 
reductions in transcript levels. By 24 hours, c-myc 
transcript levels approached control levels. 
The effects of drug treatment on steady state transcripts 
of c-fos are shown in Figure 11. Like c-myc, c-fos expression 
was elevated immediately following drug removal. In this 
case, levels of c-fos transcripts were seen to increase 3- and 
4-fold, for 1 and 3 log cell kill exposures, respectively. 
At 6 to 24 hours after drug exposure, c-fos levels returned 
to, or fell below, the very low basal levels observed in 
control cultures. 
Rapid increases in c-myc and c-f os mRNA occur in many 
cell types following external stresses, and are most often 
associated with proliferative stimuli. In the experiments 
presented here, however, an increase is seen following 
exposure to cytotoxic agents with anti-proliferative actions. 
Experiments were performed to determine if these increases are 
as rapid as those seen following proliferative stimulation. 
Figure 12 illustrates the effects of 25 µM L-PAM on c-myc and 
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c-fos expression after 15, 30, and 60 minutes following the 
addition of L-PAM. Increases in the steady state expression 
of both c-myc and c-fos can be seen within 15 minutes of drug 
addition. These increases, which were observed following 
cytotoxic insult, occur in the same time frame that increases 
in c-myc and c-fos occur following proliferative stimulation. 
Because of cell manipulation during the 24 hour time 
course (i.e. washing of cells to remove drug, addition of 
fresh media), experiments were performed to determine if c-
myc transcript levels changed after a mock drug treatment. 
Figure 13 shows Colo320 HSR c-myc mRNA levels over a 24 hour 
time course, after a mock drug treatment. Cells continued to 
grow exponentially over the 24 hour time course, but equal 
amounts of cells were lysed at each time point. Essentially 
no alterations in steady state c-myc mRNA levels were 
detected, and the small differences (< 20%) between the time 
points is probably due to experimental variability. 
In Figures 14 and 15, the effects of drug treatment on 
N-ras andp-actin expression are shown. N-ras is expressed 
at low levels in untreated Colo320 HSR. The three alkylating 
agents employed in this study appeared to have no discernible 
effect on N-ras expression over the 24 hour time course. 
These compounds had little or no effect on the expression of 
the constituitively expressed "housekeeping gene" p-actin. 
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Figure 7. Ethidium bromide stained 1% agarose gel of 20 µg 
of glyoxalated total cellular RNA isolated from control and 
drug treated (L-PAM) cells. The gel lanes are in the· same 
order as the subsequent Northern blot autoradiographs. 
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Figure s. Northern bolt analysis of relative levels of c-myc 
mRNA levels in varying amounts of total cellular RNA isolated 
from untreated Colo320 HSR cells. Either 5, 10, or 20 µg RNA 
samples were size fractionated on a 1% agarose gel, capillary 
transferred to nylon filters, and probed with the 420 bp c-
myc probe. Densitometry of c-myc autoradiographic signals in 
the different lanes indicated that the autoradiographic signal 
increased proportionally to the amount of filter-bound RNA in 
each lane. 
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Figure 9. Northern blot analysis of relative levels of N-ras 
mRNA levels in varying amounts of total cellular RNA isolated 
from untreated Colo320 HSR cells. Either 20, 40, 60, or 80 
µg RNA samples were size fractionated on a 1% agarose gel, 
capillary transferred to nylon membranes, and probed with the 
350 bp N-ras probe. Densitometry of N-ras autoradiographic 
signals in the different lanes indicated that the 
autoradiographic signal increased proportionally to the amount 
of filter-bound RNA in each lane. 
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Figure 10. Northern blot analysis of the effect of alkylating 
agents on the expression of the 2. 7 kb c-myc mRNA. Total 
cellular RNA was isolated at specified times after an one hour 
drug exposure. 20 µ.g RNA samples were denatured, size 
fractionated on 1% agarose gels, capillary transferred to 
nylon filters, and probed with the 420 bp c-myc probe. 
Exposure times of the autoradiographs was less than five hours 
using intensifying screens. 
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Figure 11. Northern blot analysis of the effects of 
alkylating agents on the expression of the 2.2 kb c-fos mRNA. 
Total cellular RNA was isolated at specified times after an 
one hour drug exposure. 40 µg RNA samples were denatured, 
size fractionated on 1% agarose gels, capillary transferred 
to nylon filters, and probed with the 1 kb v-fos prob~. 
Exposure times of the autoradiographs was three to four,days 
with intensifying screens. 
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Figure 12. Northern blot analysis of the effects of L-PAM on 
the expression of c-myc and c-fos mRNA. Total cellular RNA 
was isolated at specified times after the addition of 25 µM 
L-PAM. Either 20 µg (c-myc) or 40 µg (c-fos) RNA samples were 
denatured, size-fractionated on 1% agarose gels, capillary 
transferred to nylon filters and probed with either the 420 
bp c-myc probe or the 1 kb v-fos probe. Exposure times of the 
autoradiographs was less than five hours for the c•myc 
northern blots and three days for the c-fos northern blots. 
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Figure 13. Northern blot analysis of c-myc mRNA levels over 
the 24 hour time course, following a mock-drug treatment. 
Total cellular RNA was isolated, and 20 µg RNA samples were 
size fractionated on 1% agarose gels, capillary transferred 
to nylon filters, and probed with the 420 bp c-myc probe. 
Exposure times of the autoradiographs was less than five hours 
with intensifying screens. 
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Figure 14. Northern blot analysis of the effects of 
alkylating agents on the expression of the 4.6 kb N-ras mRNA. 
Total cellular RNA was isolated at various times after an one 
hour drug exposure. 40 µg RNA samples were size fractionated 
on 1% agarose gel, capillary transferred to nylon filters, and 
probed with the 350 bp N-ras probe. Exposure times of the 
autoradiographs was four to five days using intensifying 
screens. 
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Figure 15. Northern blot analysis of the effects of 
alkylating agents on the expression of the 2. o kb ~ -actin 
mRNA. Total cellular RNA was isolated at various times after 
an one hour drug exposure. 20 µ.g RNA samples were size 
fractionated on a 1% agarose gel transferred to nylon 
filters, and probed with the 770 bp"A-actin probe. Exposure 
times of the autoradiographs were fess than 12 hours using 
intensifying screens. 
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HN2-Induced DNA Interstrand Crosslinks in Colo320 HSR 
The temporal relationship between the changes in oncogene 
expression, and the induction and removal of DNA interstrand 
crossl inks, was examined. Over the 2 4 hour time course, total 
genomic DNA interstrand crosslinks were measured by the 
alkaline elution technique. Gene-specific DNA interstrand 
crosslinks were measured by a Southern blot analysis which was 
modified by the use of DNA denaturation/renaturation gel 
electrophoresis. 
Alkaline Elution studies 
Exponentially-growing Colo320 HSR cells (at 4-5 x 105/ml) 
were exposed to varying concentrations of HN2 (2.1, 6.3, or 
12.6 µM); L-PAM (6.25, 12.5, or 25 µM); or 4-HC (25, 50, or 
100 µM) for one hour. Control and drug-treated cells were 
resuspended in fresh media, and assayed for DNA interstrand 
crosslinks at o, 6, 12 and 24 hours after drug removal. 
In Figures 16 19, the relative levels of DNA 
interstrand crosslinks produced by different concentrations 
of L-PAM over the 24 hour time course are shown. These plots 
demonstrate that the level of DNA interstrand crosslinks 
produced is concentration dependent. 
differences in the relative levels 
Furthermore, visible 
of DNA interstrand 
crosslinks at the different time points are apparent, and 
indicate that length of post-drug exposure time is necessary 
in the production and removal of DNA interst..and crosslinks. 
78 
Figures 20 - 23 and 24 - 27 also are time- and concentration-
dependent plots of the alkaline elution assay performed on 
colo320 HSR exposed to varying concentrations of 4-HC and HN2, 
respectively. Like L-PAM, the relative levels of DNA 
interstrand crosslinks produced by 4-HC and HN2 are 
concentration-dependent, and are influenced by post-drug 
exposure incubation times. 
The relative levels of DNA interstrand crosslinks were 
converted to quantitative rad equivalents. Rad equivalents 
are the apparent amount of X-rays (in rads) by which DNA 
interstrand crosslinks slow the elution rate of DNA from drug 
treated cells exposed to 300 rads compared to untreated cells 
exposed to 300 rads. Figure 28 shows the level of DNA 
interstrand crosslinks (in rad equivalents) produced by each 
of the three doses of the three drugs at O, 6, 12, and 24 
hours after drug removal. Clearly, these compounds produce 
DNA interstrand crosslinks in a concentration-dependent 
fashion. Both 4-HC and L-PAM produce their maximal number of 
DNA interstrand crosslinks in Colo320 HSR cells approximately 
6 hours after drug removal. In contrast, HN2 produces its 
maximal number of DNA interstrand crosslinks immediately after 
drug exposure. Six hours after drug removal, however, Colo320 
HSR cells exposed to HN2 had similar levels of DNA interstrand 
crosslinks (as measured by rad equivalents) as did the Colo320 
HSR cells exposed to either 4-HC or L-PAM. By 12 hours after 
drug exposure HN2-induced DNA interstrand crosslinks were 
79 
1.0 ... -------------------------, 
0 
UJ 
z 
0.9 
0.8 
0.7 
0.6 
0.5 
< 
..... 0.4 
w 
a: 
< 
z 
0 
() 0.3 
'¢ 
... 
z 
0 
..... 
() 
<t 
c: 
u. 
0.2 
• - control 
A.-6.25um 
+ -12.5 um 
• - 25 um 
L-PAM 
0 HOUR 
o.1L..-1..-.L--1..--J.-.--"'----"'------.._-----.....o.._ ___________ • 
1.Q 0.8 0.6 04 0.2 
FRACTION 3H DNA RETAINED 
Figure 16. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of L-PAM, and assayed for DNA 
interstrand crosslinks at o hours after L-Pam exposure. 
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Figure 17. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of L-PAM, and assayed for DNA 
interstrand crosslinks at 6 hours after L-Pam exposure. 
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Figure 18. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of L-PAM, and assayed for DNA 
interstrand crosslinks at 12 hours after L-Pam exposure. 
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Figure 19. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of L-PAM, and assayed for DNA 
interstrand crosslinks at 24 hours after L-Pam exposure. 
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Figure 20. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of 4-HC, and assayed for DNA 
interstrand crosslinks at o hours after 4-HC exposure. 
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Figure 21. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of 4-HC, and assayed for DNA 
interstrand crosslinks at 6 hours after 4-HC exposure. 
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Figure 22. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of 4-HC, and assayed for DNA 
interstrand crosslinks at 12 hours after 4-HC exposure. 
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Figure 23. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of 4-HC, and assayed for DNA 
interstrand crosslinks at 24 hours after 4-HC exposure. 
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Figure 24. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of HN2, and assayed for DNA 
interstrand crosslinks at o hours after HN2 exposure. 
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Figure 25. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of HN2, and assayed for DNA 
interstrand crosslinks at 6 hours after HN2 exposure. 
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Figure 26. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of HN2, and assayed for DNA 
interstrand crosslinks at 12 hours after HN2 exposure. 
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Figure 27. DNA alkaline elution profiles of Colo320 HSR cells 
exposed to varying doses of HN2, and assayed for DNA 
interstrand crosslinks at 24 hours after HN2 exposure. 
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virtually gone, although significant levels of 4-HC and L-PAM 
induced crosslinks were still present. Approximately 50% of 
the maximal amount of DNA interstrand crosslinks produced by 
each concentration of 4-HC and L-PAM remained 24 hours after 
drug removal. 
High levels of DNA interstrand crosslinks occur at the 
time of maximal inhibition of c-myc steady state transcript 
levels (six hours after drug removal). By 24 hours after drug 
removal most DNA interstrand crosslinks are gone, which is the 
time c-myc steady state transcript levels approach those seen 
in untreated controls. Thus, a viable possibility remains that 
gene-specific crosslinks are responsible for the inactivation 
of the c-myc gene, and the subsequent depression of steady 
state c-myc transcripts. 
Measurement of Gene-Specific DNA Interstrand Crosslinks 
Experiments were designed to determine if DNA interstrand 
crosslinks produced within the amplified c-myc oncogene were 
present at the time of maximal depression in the steady state 
c-myc mRNA. Exponentially-growing Colo320 HSR (at 4-5 x 
105/ml) were treated with either 2.1, 6.3, or 12.6 µM HN2 for 
1 hour. Genomic DNA was isolated from control and HN2-treated 
cells immediately after exposure to HN2 (0 hour), and after 
a 6 hour post-exposure incubation. Experiments were designed 
such that cells from both time points (0 and 6 hour) could be 
lysed for DNA preparation at the same time. Upon exposure to 
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HN2 cell growth ceased, and approximately equal numbers of 
cells were lysed for each time point. 
Purified, high molecular weight DNA isolated from control 
and HN2-treated Colo320 HSR cells was digested with a 
restriction enzyme (Eco RI), and the DNA interstrand 
crosslinks were measured in defined genomic restriction 
fragments. The resulting restriction fragments were either 
denatured by the addition of formamide (final concentration 
65%) and heated at 65°C for 5 minutes, or allowed to remain 
in native double-stranded form. Denatured and native DNA 
samples then were size-fractionated on a neutral agarose gel. 
Following electrophoresis, the gel was Southern-blotted and 
hybridized to probes specific for defined genomic restriction 
fragments. Hybridization with the 420 bp, exon 2 specific c-
myc probe led to the recognition of a 12.5 kb EcoRI fragment 
containing the entire c-myc oncogene. Hybridization with the 
350 bp exon 1 specific, N-ras probe led to the recognition of 
a 9.7 kb EcoRI fragment containing the entire N-ras oncogene. 
Finally, hybridization with the 1.7 kb a-satellite DNA probe 
led to the recognition of a 1.7 kb EcoRI fragment containing 
the a-satellite higher order array of chromosome 20. 
To ensure accurate measurement of signal intensity on the 
autoradiographs, experiments were done to determine if the 
probe concentration was in excess of filter-bound sequences, 
under the hybridization conditions used. Figure 29 represents 
an autoradiograph of a filter with 2.5, 5.0, 10.0, or 15.0 µg 
94 
of EcoRI-digested, Southern-transferred, control Colo320 HSR 
DNA per lane hybridized with a 32P-labelled c-myc probe. 
Densitometry of the autoradiograph indicates that the c-myc 
probe is in excess of filter-bound c-myc DNA through 10 µg of 
total cellular DNA because the linear increase in the c-myc 
autoradiographic signal is maintained only through the 10 µg 
DNA sample. Thus, 10 µg of EcoRI-digested Colo320 HSR DNA was 
used for all subsequent experiments. 
Figure 30, shows the formation and disappearance of HN2-
induced DNA interstrand crosslinks in the 12. 5 kb EcoRI 
restriction fragment containing the entire c-myc oncogene. 
Immediately after the removal of HN2, a concentration-
dependent increase in DNA interstrand crosslinks within the 
c-myc oncogene was seen, however, by six hours after drug 
removal, no c-myc-specific DNA interstrand crosslinks could 
be detected. 
Figure 31 is a graph which shows the frequency of DNA 
interstrand crosslinks in the c-myc oncogene calculated from 
the Poisson distibution, and is based on the the complement 
of the zero class (-ln Pa). Pa values used were the means from 
three independent experiments(+/- S.D.), and are as follows: 
2.1 µM = 0.987 (0.001), 6.3 µM = 0.969 (0.008), and 12.6 µM 
= 0.942 (0.017). 
Figure 32 represents an autoradiograph in which the N-
ras oncogene was assayed for DNA interstrand crosslinks. No 
DNA interstrand crosslinks in this weakly transcribed gene 
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could be detected. 
Figure 33 shows a picture of an autoradiograph in which 
DNA interstrand crosslinks within the heterochromatic a-
satelli te DNA were assayed. Like N-ras, no DNA interstrand 
crosslinks in this non-transcribed region were detected. 
Effect of HN2 Treatment on DNA Synthesis in Colo320 HSR 
Colo320 HSR cells were exposed to O, 2.1, 6.3, or 12.6 
µM HN2 for one hour, and 3H-thymidine incorporation as a 
measure of DNA synthesis was assayed at varying times up to 
six hours after drug removal. DNA synthesis in drug-treated 
cells was then plotted relative to DNA synthesis in untreated 
control cells (corrected for cell number). Figure 34 
illustrates the results of these experiments. 
Exposure of Colo320 HSR cells to HN2 caused a 
concentration- and time-dependent inhibition of DNA synthesis. 
One hour after drug removal, 3H-thymidine incorporation into 
Colo320 HSR cells exposed to 2.1 µM HN2 was 65.7% of control; 
in cells exposed to 6.3 and 12.6 µM HN2, 3H-thymidine 
incorporation was 37.7% and 28.2% of control, respectively. 
Three and one-half hours after drug removal, 3H-thymidine 
incorporation in cells exposed to 2.1, 6.3, and 12.6 µM HN2 
was 28.5%, 13.0%, and 7.9% of control, respectively. Finally, 
6 hours after drug removal, 3H-thymidine incorporation in 
cells exposed to 2.1, 6.3, and 12.6 µM HN2 was 18.5%, 5.4%, 
and 2. 9% of control, respectively. These results confirm that 
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HN2 inhibits DNA synthesis, and suggests that little DNA 
replication was occurring following drug exposure. 
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Figure 29. Southern blot analysis of the relative levels of 
the c-myc gene in varying amounts of genomic DNA isolated from 
untreated Colo320 HSR cells. DNA was digested with the 
restriction enzyme EcoRI, and varying amounts of DNA (2.5, 5, 
10, and 15 µg) were size fractionated on a 0.5% agarose gel, 
capillary transferred to a nylon filter, and probed with the 
420 bp c-myc probe. Densitometry of the c-myc 
autoradiographic signal indicated the signal increased 
proportionally to the amount of filter-bound DNA from 2.5 µg 
to 10 µg; thereafter the filter-bound DNA was in excess of the 
probe concentration, and the proportional increase in 
autoradiographic signal was lost. 
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Figure 30. Detection and disappearance of DNA interstrand 
cross links in the c-myc oncogene by DNA 
denaturation/renaturation gel electrophoresis and Southern 
blot analysis. Colo320 HSR cells were exposed to varying 
concentrations of HN2 for one hour. Genomic DNA was isolated 
at o and 6 hours following HN2 exposure, and digested with 
EcoRI. Denatured and native DNA samples (10 µg/lane) were 
size-fractionated on O. 5% neutral agarose gels, capillary 
transferred to nylon membranes, and probed with the 420 bp c-
myc probe. Nylon membranes were autoradiographed, ·with 
intensifying screens for appropriate periods of time. 
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Frequency of DNA Interstrand Crosslinks/ 
c-myc Oncogene following HN2 Exposure 
• 
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Figure 31. The frequency of DNA interstrand crosslinks in the 
c-myc oncogene immediately following a one hour exposure to 
2. 1, 6. 3, or 12. 6 µM HN2. Calculations of interstrand 
crosslinks were determined from the Poisson distibution, and 
ignore the small fraction of DNA molecules that would have 
more than one DNA interstrand crosslink. The value of the 
zero class (P0 ) used in the calculations was the mean of three 
independent experiments. 
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Figure 32. Absence of DNA interstrand crosslinks in the N-
ras oncogene as assayed by DNA denaturation/renaturation gel 
electrophoresis and Southern blot analysis. Colo320 HSR cells 
were exposed to varying concentrations of HN2 for one hour. 
Genomic DNA was isolated at O and 6 hours following HN2 
exposure, and digested with EcoRI. Denatured and native DNA 
samples (10 µg/lane) were size-fractionated on 0.5% neutral 
agarose gels, capillary transferred to nylon membranes, and 
probed with the 350 bp N-ras probe. Nylon membranes were 
autoradiographed, with intensifying screens for appro~riate 
periods of time. 
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Figure 33. Absence of DNA interstrand crosslinks in a-
satellite DNA from chromosome 20 as assayed by DNA 
denaturation/renaturation gel electrophoresis and Southern 
blot analysis. Colo320 HSR cells were exposed to varying 
concentrations of HN2 for one hour. Genomic DNA was isolated 
at o and 6 hours following HN2 exposure, and digested with 
EcoRI. Denatured and native DNA samples (10 µg/lane) were 
size-fractionated on O. 5% neutral agarose gels, capillary 
transferred to nylon membranes, and probed with the 1.7 kb a-
satellite probe. Nylon membranes were autoradiographed, "with 
intensifying screens for appropriate periods of time. 
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Figure 34. Measurement of Colo320 HSR 3H-thymidine 
incorporation, at various time points, following a one hour 
exposure to 2.1, 6.3, or 12.6 µM HN2. Values are expressed 
as the percent of the mean incorporation (+/- S.D.) of 3H-
thymidine as compared to untreated control cells. 
DISCUSSION 
In this dissertation, an attempt was made to delineate 
the effects of bifunctional alkylating agents on the structure 
and function of particular oncogenes in a human tumor cell 
line. studies presented here confirm that bifunctional 
alkylating agents can affect specifically the expression of 
the c-myc and c-fos oncogenes. Subsequent experiments were 
performed to determine if nitrogen mustard-induced DNA 
interstrand crosslinks in the c-myc oncogene were responsible 
for the decreased expression observed in this gene 6 to 12 
hours after drug exposure. The experimental results indicate 
that there is not a temporal relationship between the 
production of c-myc-specif ic DNA interstrand crosslinks and 
decreased gene expression; however, it is possible that the 
induction of DNA interstrand crosslinks within a transcribed 
gene is responsible ultimately for the transcriptional 
inactivation of that gene. The results further suggest that 
nitrogen mustard-induced DNA interstrand crosslinks may 
preferentially modify highly transcribed sequences, and that, 
overall the lesions in highly transcribed sequences were 
removed more rapidly than from the genome. 
N7 Guanine Alkylation Studies 
Initial studies were designed to examine if HN2, L-PAM, 
or C-2 demonstrated any sequence-specific differences in their 
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reaction with a defined, double-stranded DNA fragment in 
vitro. Although in this assay, sequence specificity of the 
nitrogen mustards is assessed by their ability to react with 
naked DNA, it has been demonstrated that HN2 will modify the 
same DNA sequences in intact cells; albeit to a far lesser 
extent (Grunberg and Haseltine, 1980). 
A 420 bp PstI restriction fragment from exon 2 of the 
human c-myc oncogene, originally cloned from Colo320 HSR, was 
used as the defined DNA fragment, and was exposed to varying 
concentrations of HN2, L-PAM, or C-2. When this DNA fragment 
was assayed for drug-induced N7 guanine alkylations, none of 
the compounds demonstrated differences in their ability to 
react with sequences of alternating guanines and cytosines -
the sequence necessary for the formation of the DNA 
intestrand crosslink. All three compounds displayed a slight 
preference for contiguous runs of three or more guanines. 
This previously was reported for a number of other DNA-
damaging anti-tumor agents (cis-Pt, BCNU, HN2)(Mattes et al., 
1988), and is even seen for dimethyl sulfate, which is used 
for the guanine-specific reaction in the standard Maxam and 
Gilbert DNA sequencing procedure. Differences did exist, 
however, in the relative reactivity of these compounds with 
the DNA (L-PAM > HN2 > C-2). This does not necessarily mean 
L-PAM reacts more frequently with cellular DNA than the other 
two compounds. A number of cellular processes may negate this 
enhanced reactivity seen in naked DNA. For instance, 
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decreased drug influx (or increased drug efflux) or 
differential reactivity with cellular drug scavengers (e.g. 
glutathione) may decrease the amount of drug available to 
react with the DNA (Bellamy et al., 1988, Lee et al., 1989). 
Although these bifunctinal alkylating agents do not 
display differences in their sequence selectivity in reacting 
with the N7 position of guanine, recent work suggests that 
other, less frequent, lesions may be involved in terminating 
RNA transcription. Using an in vitro transcription system, 
it was demonstrated that HN2 produced transcription-
terminating lesions at select guanine pairs along the DNA 
template, L-PAM produced transcription terminating lesions at 
adenine pairs, but C-2 produced no transcription terminating 
lesions (Pieper et al., 1989). This assay does not directly 
address the potential effects of the DNA interstrand 
crosslink, but does demonstrate differences between the 
bifunctional alkylating agents in their potential ability to 
disrupt transcription in intact cells. 
Gene Expression Studies 
The exposure of bifunctional alkylating agents to Colo320 
HSR was able to modulate the expression of specific oncogenes 
in Colo320 HSR, as measured by Northern blot analysis. The 
steady state expression of c-myc and c-fos were affected, but 
the steady state expression of N-ras and p-actin were not. 
Furthermore, each compound elicited similar responses. 
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In the 24 hours following exposure to bifunctional 
alkylating agents, little or no change in the steady state 
levels of N-ras and (>-actin was observed. This is not 
surprising since most other compounds have had little or no 
effect on the expression of these two genes. Furthermore, 
changes in the levels of p-actin may not be readily 
discernible because of the long t 1/2 of the ~actin mRNA 
(Watanabe et al., 1985, Mitchell et al., 1986, Kharabanda et 
al. I 1989) • 
The mRNA levels of c-f os and c-myc were elevated 
immediately following drug exposure. c-fos mRNA can be 
increased rapidly by a disparate group of stimuli, and recent 
reports indicate that DNA damaging agents, other than 
bifunctional alkylating agents, can increase c-fos expression 
(Fornace et al., 1989). The reason for this increase is not 
understood, but the c-fos protein is a transcriptional 
regulator which plays a role in stimulating or repressing the 
transcription of genes under the influence of the AP-1 
inducible enhancer (Chiu et al., 1988, Distel et al., 1987). 
It also has been reported that genes inducible by the DNA 
damaging agents Mitomycin c and UV light are also AP-1-
inducible genes (Angel et al., 1986, 1987a, 1987b). From 
these observations it is possible to speculate that the 
bifunctional alkylating agents are inducing a cellular 
response to DNA damage mediated through the induction of the 
c-fos gene. 
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The rapid increases in c-f os and c-myc expression are 
seen consistently in the cellular mitogenic response (Armelin 
et al., 1984, Muller et al., 1984). Thus, the increases in 
expression of c-myc and c-f os seen after nitrogen mustard 
exposure are surprising, since the cellular response to 
nitrogen mustard exposure is both rapid and cytotoxic, as 
evidenced by the experiments measuring DNA synthesis and the 
colony formation assays. If c-myc and c-fos increases are due 
to increased transcription, the intracellular signalling 
pathways mediating these respective increases may be 
independent of one another, and/or different from the pathways 
mediating the proliferative response. This is consistent with 
observations demonstrating that the induction of c-f os and c-
myc transcription can occur via a number of different 
intracellular signalling pathways (Hall and Stiles, 1987, 
Grausz et al., 1986, Mccaffrey et al., 1987). 
Finally, it is also possible that the increase in c-fos 
and c-myc mRNA levels is due to a drug-induced stabilization 
of these mRNA. While possible, this type of effect may 
ultimately lead to the same biological consequences as 
increased transcription. 
Each of the bifunctional alkylating agents tested were 
able to suppress the level of c-myc mRNA transcripts at 6 and 
12 hours following drug exposure. Suppression of c-myc 
transcripts by a variety of other compounds prevously has been 
reported. In each case decreased levels of c-myc transcripts 
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was associated with cessation of cellular proliferation and/or 
cellular differentiation. 
Specifically, agents such as dibutiryl cyclic-AMP, DMSO, 
and 1, 25 ,-dihydroxy vitamin D3 reduce c-myc expression in 
human hematologic tumor cell lines prior to terminal 
differentiation (Watanabe et al., 1985, Trepel et al., 1987, 
Reitsma et al., 1983). The anti-tumor agents 6-thioguanine 
and 1- -D-arabinofuranosylcytosine given at doses that induce 
terminal differentiation in human hematologic tumor cell lines 
caused decreases in c-myc mRNA (Mitchell et al., 1986, 
Schwartz and Eninger, 1989). Finally, exposure to interferon 
a caused growth arrest in the Burkitt lymphoma cell line 
Daudi, and interferon gamma alone, or in cooperation with 
tumor necrosis factor, caused growth arrest in HeLa cells 
(Yarden and Kimichi, 1986, Einat et al., 1985). 
Like the agents listed above, the depression of c-myc 
mRNA observed following nitrogen mustard exposure may be due 
to a cellular response specif c for growth arrest or perhaps 
cell death. Alternatively, it also is possible that the 
suppression of c-myc transcript levels may be due to the 
accumulation of DNA damage (DNA interstrand crosslinks, in 
particular) within the c-myc oncogene. 
DNA Interstrand Crosslinking Studies 
Total genomic DNA interstrand crosslinks produced by HN2, 
L-PAM, and 4-HC were measured by the DNA alkaline elution 
technique. 
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The results obtained in Colo320 HSR cells were 
consistent with results in similar studies using other cell 
lines (Erickson et al., 1980). The production of drug-induced 
DNA interstrand crosslinks increased in a concentration-
dependent fashion and the levels of DNA interstrand crosslinks 
were related directly to levels of drug-induced cytotoxicity. 
Peak levels of DNA interstrand crosslinks were observed 
6 hours after exposure to 4-HC and L-PAM. Levels of 
crosslinks produced by HN2 were comparable to 4-HC and L-PAM 
at 6 hours, however, interstrand crosslinks peaked immediately 
after exposure to HN2 ( o hour) . Fol lowing the respective peak 
times of DNA interstrand crosslinks, the levels of interstrand 
crosslinks decayed over the remainder of the 24 hours. 
High levels of DNA interstrand crosslinks at six hours 
following drug treatment suggested gene-specific DNA 
interstrand crosslinks may be responsible for the decreased 
express ion of the c-myc oncogene. This poss ibi 1 i ty was tested 
by measuring HN2-induced DNA interstrand crosslinks in defined 
DNA restriction fragments isolated from HN2-treated Colo320 
HSR cells. The defined restiction fragments were specific for 
the entire human c-myc oncogene, the entire human N-ras 
oncogene, and the a-satellite DNA specific for human 
chromosome 20. 
DNA interstrand crosslinks were observed in the c-myc 
oncogene immediately following exposure to HN2. Moreover, the 
levels of crosslinks in this highly transcribed gene increased 
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in a concentration-dependent fashion. No HN2-induced DNA 
interstrand crosslinks could be detected in the N-ras 
oncogene, which is transcribed at low levels, nor the non-
transcribed a-satellite sequences. 
These results suggest that the HN2-induced DNA 
interstrand crosslinks may display intragenomic preferences 
in reactivity. The absence of DNA interstrand crosslinks in 
a-satellite DNA may reflect the fact that it is -60% A-T; 
based on its consensus sequence (Willard, 1987). 
Additionally, in this sequence few sites exist where a DNA 
interstrand crosslink can form (only 10 G-C doublets in the 
171 bp consensus sequence). The formation of the DNA 
interstrand crosslink also may be inhibited. In support of 
this possibility, is the observation that PUVA-induced DNA 
interstrand crosslinks were not formed in a-satellite DNA, 
however, monoadducts were formed in a-satellite DNA as readily 
as in bulk DNA. It has been suggested that the inhibition of 
crosslink formation is due to physical contraints imparted by 
the condensed chromatin structure of a-satellite DNA (Zolan 
et al., 1982). 
Chromatin structure also may serve to explain observed 
differences between the DNA interstrand crosslinks formed in 
the c-myc and N-ras oncogenes because both genes are high in 
G-C content and, therefore, ideal targets for the formation 
of DNA interstrand crosslinks (Mattes et al., 1988). Based 
on the Northern blot analysis, c-myc is expressed at very high 
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levels while N-ras expression barely is detectable. This 
suggests differences in their transcriptional states, and 
perhaps their chromatin structure. Evidence from other 
studies indicates that various DNA damaging carcinogens and 
chemotherapeutic agents preferentially modify and crosslink 
the transcriptionally active fraction of the genome. Finally, 
from the Poisson distribution and the DNA interstrand 
cross links observed in the c-myc oncogene, there is one 
interstrand crosslink approximately every 200 kb of DNA in 
Colo320 HSR cells exposed to 12. 6 µM HN2 for one hour 
(ignoring the small fraction of fragments with greater than 
one crosslink). Based on 6. 6 x 109 bp per human diploid 
genome (probably far less DNA than the aneuploid Colo320 HSR 
cells contain), 12. 6 µM HN2 would produce approximately 33, ooo 
DNA interstrand crosslinks. This is in great excess of the 
100 - 1000 DNA interstrand crosslinks thought to occur in 
tumor cells exposed to cytotoxic concentrations of nitrogen 
mustards, however, it is not contradictory if intragenomic 
heterogeneity exists in the formation of HN2-induced DNA 
interstrand crosslinks. 
Six hours after exposure to HN2, all DNA interstrand 
cross links in the c-myc oncogene have disappeared. This 
disappearance of DNA interstrand crosslinks in the c-myc 
oncogene does not appear to be a dilutional effect produced 
by synthesis of damage-free replicated DNA because DNA 
synthesis was effectively inhibited by drug exposure. By 
112 
contrast, > 50% of the DNA interstrand crosslinks remained in 
the total genome. Although the assays used to measure DNA 
interstrand crosslinks in specific genes and the total genome 
were not the same, the large differences observed between the 
c-myc oncogene and the total genome indicates there may be 
heterogeneity in the removal of HN2-induced DNA interstrand 
crosslinks. Again, DNA topology and gene activity may explain 
the removal of DNA interstrand crosslinks from the c-myc 
oncogene. A growing body of work demonstrates that 
transcriptional activity and chromatin structure are important 
factors in the preferential removal of aflatoxin B1 adducts, 
PUVA-induced DNA interstrand crosslinks, and UV-induced 
pyrimidine dimers 
Snowden, 1988). 
(Leadon, 1986, Dean, 1989, Leadon and 
In fact, it has been suggested that high 
levels of transcription are necessary for the removal of many 
types of DNA damage (Mellon and Hanawalt, 1987). If 
transcription is necessary for the removal of at least some 
DNA lesions, then this may explain the rapid disappearance of 
DNA interstrand crosslinks in the c-myc oncogene. The 
increased levels of c-myc mRNA transcripts observed 
immediately following drug exposure are consistent with this 
possibility. 
The absence of DNA interstrand crosslinks in the c-myc 
oncogene 6 hours following HN2 exposure indicates that gene-
specif ic DNA interstrand crosslinks are not responsible 
temporally for the inactivation of this gene. It does not, 
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however, exclude the possibility that the persistence of other 
DNA interstrand crosslinks in other areas of the genome are 
indirectly responsible for the inhibition of c-myc expression, 
or the initial DNA interstrand crosslinks formed in the c-myc 
oncogene are responsible for the inactivation of this gene. 
Finally, it should be mentioned that the removal of DNA 
interstrand crosslinks, as measured by the assays used in this 
dissertation, reflects the disappearance of the lesion, but 
not necessarily the complete repair of the damage. Like many 
other repair pathways of DNA damage, repair of the interstrand 
crosslink is probably multi-step and multi-enzymatic. The 
first step in the repair process is thought to be the 
"unhooking" of one arm of the interstrand crosslink (Reid and 
Walker, 1969). This is the event observed as the 
disappearance of DNA interstrand crosslinks in the assays 
used. If inhibition of strand separation is the critical 
cytotxic event, then the "unhooking" step may be the critical 
first step in the repair event. 
In summary, these experiments demonstrate that HN2, L-
PAM, and 4-HC can affect the expression of a subset of active 
genes. The immediate increases in c-fos and c-myc expression 
observed in these studies imply a possible cellular response 
to the drug challenge. The depression of c-myc expression 
following exposure to bifunctional alkylating agents is 
similar to the responses observed following exposure to non-
DNA-damaging, therapeutic compounds, and is consistent with 
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the observed growth arrest produced by these compounds. These 
results, and the knowledge that c-myc plays a participative 
role, if not a causal role, in many human malignancies, 
suggests that inhibition of c-myc expression may ultimately 
be a targeted therapeutic endpoint or a prognostic indicator. 
Indeed, depression of c-myc expression in leukemic patients 
following chemotherapy has been correlated with a good 
response to treatment. 
The observed depression of c-myc expression 6 hours after 
exposure to HN2 does not appear to be due to the presence of 
c-myc-specif ic DNA interstrand crosslinks at this point in 
time, but the formation of DNA interstrand crosslinks in the 
c-myc gene immediately after drug exposure may be responsible 
for transcriptional inactivation of c-myc. Furthermore, 
experimental evidence implies that HN2-induced DNA interstrand 
crosslinks are produced and processed in the genome in a 
heterogeneous fashion. Analysis of observed subgenomic 
differences in the formation and disappearance of DNA 
interstrand crosslinks may ultimately aid in the delineation 
of specific genomic regions necessary for the formation and 
maintenance of critical cellular lesions. 
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